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INTRODUCTION 
Since the original isolation of western equine 
encephalomyelitis (WEE) virus by Meyer et^al. (39) in 
1930, many new laboratory techniques have become avail­
able for the detailed study of animal viruses. One of 
the most significant advancements was the introduction 
of the cell culture plaque technique by Dulbecco (15), 
first reported in 1952. A virus population that can 
be prepared by selecting and propagating the virus 
harvested from one isolated plaque, theoretically 
represents the progeny of an individual parent particle. 
Thus, by employing the plaque technique, the virologist 
for the first time was able to select variants from 
among the original population in order to study and 
compare their individual properties. Significant 
variations in the characteristics of the newly-derived 
sub-populations have often been discovered. 
Application of selective cloning procedures to 
populations of WEE virus have resulted in numerous 
recent reports which reveal the heterogeneity of 
this virus. These findings have established that many 
WEE virus isolates are composed of mixtures of subtypes 
which may vary with respect to plaque diameters in 
cell cultures, virulence for laboratory animals, or 
antigenic characteristics. 
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The subject of WEE virus heterogeneity has been 
quite extensively investigated by a number of different 
research groups. However, as the subsequent review of 
the literature will indicate', some discrepancies appear 
in the results reported, and some of the following 
questions could be raised. Are there two, three, or 
more plaque-size variants of WEE virus? Under what 
conditions is each type most likely to be found? Is 
the change in plaque size which one encounters during 
serial passage due to a true genetic change, or just the 
result of host selection from among an impure population? 
And, is it possible that the plaque-size marker is an 
indicator of variation in other biological properties 
such as virulence or antigenic characteristics? 
The study to be reported here is an investigation 
of the biological properties of three plaque-size variants 
of WEE virus which have been cloned from one original 
parent strain. It was undertaken as an attempt to 
answer some of these questions, and as an attempt to 
resolve some of the discrepancies appearing in the 
literature to be cited. 
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REVIEW OF THE LITERATURE 
Variation in Plaque Diameter 
Introduction 
One of the few visible clues available to the 
virologist for use in the identification of an animal 
virus is its characteristic plaque diameter in cell 
cultures. Plaque diameter is a readily measurable 
property of^ a virus, but unfortunately like many other 
biological properties, it may be observed to vary. 
In fact, there are two types of plaque-size variation. 
One type depends upon the environmental conditions under 
which plaque diameters are determined. The second type 
of variation can be attributed to changes in the properties 
of the virus itself. 
The environmental factors responsible for the first 
type of variation have been quite adequately reviewed by 
a number of authors (1, 12, 13, 17, 33 and 41). Among 
those factors mentioned are the species of origin and the 
type of cell culture in which the virus is titrated. The 
conditions that are maintained during the incubation of 
infected cultures, such as the chemical composition of the 
overlay medium, the temperature, the pH and the time 
allotted for plaque development also significantly affect 
plaque size. 
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However, even under constant and controlled en­
vironmental conditions, differences may still be detected 
in the diameter of the plaques produced by some viruses. 
This second type of variation, which in the case of WEE 
virus is associated with the existence of plaque-size 
variants, was the principal topic of this research project. 
Therefore, the articles cited in the following"review of 
the literature will be those which directly pertain to 
this second type of variation in plaque diameter. 
WEE virus plaque-size variants 
Quersin-Thiry (48) was the first research worker 
to report the existence of a so-called small-plaque (SP) 
"mutant" of WEE virus. After 36 hours of incubation in 
primary chicken embryo fibroblast (CE) monolayer cell 
cultures, the average SP diameter was only 1.0 mm., in 
contrast to the 6.0 mm. average diameter of the large-
plaque (LP) "wild type". 
Three plaque types of WEE virus were described by 
Marshall £t al. (34) in a later publication. When their 
diameters were measured after 5 days in CE cells, these 
plaques could be classified as SP (1.3 to 3.0 mm.), 
medium plaque or MP (approximately 5.0 mm.) and LP 
(7.6 to 13.0 mm.). 
Neither Quersin-Thiry nor Marshall's group dis­
cussed the effect of agar overlay composition on the 
relative plaque size of WEE virus variants. 
Relation of agar overlay components to plaque-size 
variation of other viruses 
In i960, Nomura and Takemori (44) reported the 
existence of plaque-size mutants of polio virus. 
Takemori and Nomura (5^) then demonstrated a probable 
cause for the differences in plaque diameters. They 
suggested that it was due to a relative difference in 
the susceptibility of the mutants to the inhibitory 
effects of a component of Noble agar which was used in 
the overlay medium. 
Similar observations were made by Takemoto and 
Liebhaber (56) in the case of plaque-size variants of 
mouse encephalomyocarditis virus. They identified the 
inhibitory agent as a sulfated polysaccharide, and were 
able to block its inhibitory activity by incorporating 
either diethylaminoethyl (DEAS) dextran or protamine 
sulfate in Noble agar overlay media (55). 
After the initial reports cited above, nearly 100 
papers soon followed — all dealing with plaque-size 
variants of many viruses in relation to agar overlay 
composition. Only those which pertain directly to the 
problem being discussed will be reviewed here. 
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Inhibitors of WEE virus plaque development 
The effect of the agar inhibitor on V/EE virus was 
first mentioned in a paper by Ushijima et al. (57). They 
observed two plaque types which measured 2.0 and 6.0 mm. 
respectively, after 5^ hours under Noble agar overlays 
on CE cells. Under methyl cellulose, both plaque types 
were smaller, but the relative size difference was unchanged. 
When DEAE dextran was added to agar overlays, however, the 
average SP diameter was increased from 2.0 to 5.0 mm., 
while the LP diameter remained relatively unchanged. They 
were led to conclude therefore, that the size difference 
was primarily due to the greater sensitivity of the SP type 
to the agar inhibitor. 
As a result of work in this laboratory, done indepen­
dently from that of Ushijima's group, Brovm (3) and Brown 
and Packer (4) also reported plaque-size variants of WEE 
virus. After 48 hours in CE cell culture?, the variants 
were classified as SP (2.0 to 5.0 mm.) and LP (7.0 to 10.0 
mm.). In this instance, neither the presence of autogenous 
interferon in inocula, nor autoinhibition by heat-inactivated 
WEE virus particles were the principal cause of the retarded 
development of the small plaques. The addition of 
protamine sulfate to Noble agar overlay medium allowed 
the small plaque to achieve a diameter equal to that of 
the large. A difference in the susceptibility of the 
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variants to the agar inhibitor was therefore suggested 
as the most likely cause of the plaque-size differences 
observed. 
Using the strain of WEE virus which had been 
originally studied by Quersin-Thiry, LeClerc and 
Cogniaux-LeClerc (31) also demonstrated that the 
presence or absence of interferon is not the most 
significant factor governing plaque size variation. 
They found that both the LP and SP variants were 
equally susceptible to inhibition by interferon, and 
were equally capable of stimulating its synthesis and 
release from infected cells. They also reported the increase 
in diameter of small plaques in the presence of protamine 
sulfate. 
Interactions between arboviruses and agar extract 
Colon, Idoine, and Brand (10) were able to show that 
an extract from Noble agar inhibited replication of WEE 
virus if it was added to the fluid maintenance medium 
of infected CE cell cultures. Hemagglutination of goose 
erythrocytes was also inhibited if they were washed with 
agar extract prior to the addition of virus. These 
inhibitory effects could be reversed by either DEAE 
dextran or protamine sulfate. 
Colon and Idoine (9) later extended their studies 
to show the effectiveness of the agar-extract inhibitor 
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against preparations of infectious ribonucleic acid (RNA) 
from western (WEE), eastern (SEE) and Venezuelan (VEE) 
equine encephalomyelitis viruses. The addition of DEAE 
dextran to agar overlays reportedly caused a three- to 
four-fold increase in the diameter of the plaques obtained 
from titrations of infectious RNA on CE monolayers. 
DEAE dextran speeded the appearance and development 
of the plaques, but caused no increase in their numbers. 
Enhancement by DEAE dextran could only be demonstrated 
with a SP, attenuated type of VEE, and not with a LP 
type VEE virus which possessed greater virulence for 
mice. 
To date, one of the most detailed studies of the 
interactions between susceptible arboviruses and the 
sulfated polysaccharide inhibitor is that reported by 
Colon et aJ. (11). They demonstrated a 2-log decrease in 
titer of EEE virus following incubation with agar extract 
for 1 hour prior to plating. The interaction between 
virus and inhibitor occurred over a wide pH range. 
Increased in effect up to at least 1 hour and perhaps 
to 3 hours of incubation, and was not reversed by dilution 
of the virus-inhibitor mixture in brain-heart-infusion 
broth. 
Reduced plating efficiency of EEE virus was also 
observed after treatment of CE monolayers with agar 
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extract for 1 hour prior to infection. The inhibitory 
effects could not be completely removed by repeated 
washings of treated cells with DEAS dextran, and a cell-
inhibitor interaction was therefore postulated. Although 
sodium dextran sulfate mimics the action of agar extract 
when mixed with susceptible viruses, its effect on cells 
could be reversed by washing with DEAE dextran. The 
authors therefore suggested that there was a slight 
difference in the mode of action of the two inhibitors. 
Echovirus variant protected by cysteine 
Wallis and Melnick (58) found that the resistance 
to agar polysaccharide of a LP (Pesascek strain) 
type 4 echovirus was dependent on the presence in the 
overlay medium of a 1.0 millimolar concentration of 
cysteine. The presence of cysteine did not protect 
the SP (DuToit strain) type 4- echovirus against inhi­
bition. In a basal skim milk overlay medium (devoid of 
lactalbumin hydrolysate and low in cysteine) the LP virus 
was actually inhibited to a greater extent than was the 
SP variant. Apparently a possible protective effect of 
cysteine for WEE virus has not been investigated. 
Natural occurrence and stability of WEE variants 
Although most investigators are in agreement con­
cerning the effect of agar polysaccharides on WEE virus 
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plaque-size variants, conflicting observations are to be 
found elsewhere in their reports. The degree of hetero­
geneity in plaque diameter of newly-isolated, field strains 
is one area of disagreement. For example, Marshall et 
al. (34) indicated that of six field strains they 
isolated from mosquitoes or birds, all were found to be 
predominantly the LP variant. In contrast, Ushijima 
et al. (57) described a mosquito isolate which they 
considered to be heterogenous because it consisted of a 
mixture of SP and MP variants. 
Another controversial point is the degree of sta­
bility of the plaque-size variants during serial passage 
in several laboratory hosts. Ushijima et al. (57) re­
ported that both the LP and SP variants were stable 
during serial passages either in CE cell cultures or 
in the brains of suckling mice. Marshall et al. (3^) 
have stated that serial passage in embryonated chicken 
eggs was the only method which allowed the LP character­
istic of their field strains to be maintained. They 
observed that the SP variant quickly replaced the LP 
as the major component of the population after either 
mouse brain or CE cell culture passages. Brown and 
Packer (4) also reported that the plaque-size properties 
of a partially-purified LP population were modified by 
serial passages in CE cell cultures or in weanling mice. 
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They, In disagreement with Marshall and his coworkers, 
found a SP type appearing after passage in chicken embryos. 
A change in the opposite direction has been reported by 
Quersin-Thiry (48). According to this author, a change 
in the characteristic plaque size of a population from 
SP to LP during propagation in CE cell cultures was 
enhanced by the presence of lactalbumin hydrolysate, 
yeast extract and bovine serum in the maintenance medium. 
Variation in Virulence 
Comparative virulence of WEE plaque-size variants 
Of those workers who have reported the existence 
of WEE plaque-size variants, only Quersin-Thiry (48) 
has attempted to determine their relative virulence, 
and in that case, only for chicken embryos. No 
significant differences in virulence between the LP and 
SP variants could be found. 
Comparative virulence of plaque-size variants of other 
arboviruses 
Hardy and Heam (19) have indicated that a SP 
variant of Venezuelan equine encephalomyelitis (VEE) 
virus causes death of weanling mice only by intracran­
ial infection, and not the intraperitoneal route. 
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In contrast, the LP variant (coIncidentally, less suscep­
tible to agar polysaccharide inhibition) is fully virulent 
by both routes. VEE virus has been classified into 
three plaque types by Brown (2). All three types were 
- fully virulent for hamsters, but only the LP variant killed 
mice when injected intraperitoneally. Plaque-size 
variations of VEE virus, like WEE, were host-dependent, 
according to Heydrick et al. (23). The latter group 
has demonstrated a difference in banding patterns in 
sucrose density gradients, a difference in the ratio of 
soluble to insoluble lipids and a difference in virulence 
between VEE variants. 
St. Louis enceph^itis (SLE) virus exhibits plaque-
size heterogeneity also, as observed by Nagai et al. (42). 
They concluded that the LP and SP variants of SLE virus 
were separate genotypes which did differ in virulence for 
mice and in cytopathogeniclty for hamster kidney cell 
cultures, but which were closely related or identical in 
antigenic properties. Once again, the LP type was the more 
virulent of the two. 
Another example of a correlation between virulence 
and plaque size is from the work of Porterfield (4?). 
He observed that the neurotropic strains of yellow fever 
virus produced larger plaques in CE cells, than did the 
attenuated, ch1cken-embryo-adapted 17D strain. 
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Although Mayer (35, 36, 37 and 38) discussed essentially 
similar findings resulting from studies of Central European 
tick-borne encephalitis virus, his reports differed 
significantly in one respect. Use of inhibitor-free 
agar, or addition of protamine sulfate to the overlays 
failed to alter the relative diameter of the SP, aviraient 
variant of this virus. 
The work of Inoue and Kato (24) showed that a SP, 
thermo-efficient mutant of Japanese B encephalitis virus 
was more virulent for mice, by intranasal inoculation, than 
was the LP type of the same strain. Neither exhibited 
pathogenicity when administered to mice subcutaneously 
or intraperitoneally. In this final example, virulence 
was inversely proportional to plaque diameter. 
Changes in virulence of WEE virus with serial passage 
The virulence of WEE virus for baby chicks was 
investigated by Chamberlain et al. (5) in 195^. They 
observed that freshly isolated field strains of the virus 
routinely killed §-day-old chicks quickly and at high 
dilution after subcutaneous injection. The Flemming strain 
of WEE virus, which had undergone many serial intracranial 
passages in mice, required a much longer time interval to 
kill, produced more distinctly observable signs of central 
nervous system disorder in the chicks, and was signif­
icantly lower titered. 
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As Kissling (30) reported in 1957. "Most arboviruses, 
after continued intracranial passage, lose peripheral 
virulence.". - He cited, WEE, EEE, SLE, West Nile and Japanese 
B encephalitis viruses as typical examples. 
WEE virus heterogeneity with respect to virulence 
When Dunayevitch et a2. (18) titrated a field strain 
of WEE virus in young adult mice, they observed auto-
inhibition effects at the lower dilutions. They were 
subsequently able to clone a variant from the population 
which exhibited markedly lower virulence for the mice. 
They reasoned that the mice, inoculated at the lower 
dilutions, had been protected against the virulent virus 
by the non-pathogenic variant wi.ich coexisted with it 
in the mixed population of bird origin. 
Serial cloning of this non-pathogenic WEE virus 
was continued by Johnson (25), who selected at each 
passage level for variants of low virulence for infant 
mice. The clone 15 variant which resulted was very 
low in pathogenicity for adult mice by intracranial or 
by intraperitoneal routes, yet it conferred a strong 
immunity to subsequent challenge with neurotropic WEE 
virus. Recent studies by Kemp and Johnson (29) and 
by Roca-Garcia ^  al. (51) indicate that the clone 15 
variant shows some promise of becoming a satisfactory 
live-virus vaccine against encephalomyelitis in horses 
15 
and perhaps man. 
Plaque diameter of the clone 15 variant 
Johnson®" has stated that newly-Isolated strains of 
WEE virus usually produce large (8 to 15 mm.) plaques In 
duck embryo cell cultures. In contrast, the original 
bird isolate, from which the clone 15 variant was even­
tually derived. Initially caused the formation of Inter-
mediate-sized plaques (3 to 4 mm.) in duck embryo cell 
cultures, and a mixture of small and intermediate-sized 
plaques (actual measurements not specified) in CE cell 
cultures. Although plaque properties were not considered 
in the selection of this variant, it is of interest that, 
even in its wild state, the plaques produced by the 
parent population differed from those of the typical 
isolate. 
f  
Variation in Antigenic Properties 
Antigenic properties of WEE plaque-size variants 
Investigators of WEE plaque-size variants have 
routinely been unsuccessful In attempts to distinguish 
^Johnson, H. N., The Rockefeller Foundation, Berkeley, 
California. Unpublished observations. Private communication, 
1965. 
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between them antigenically. Quersin-Thiry (48), for 
example, observed that the LP and SP variants were 
neutralized to the same extent by antiserum from rabbits 
immunized with killed LP virus. The two variants 
studied by Ushijima et a2. (57) could not be distinguished 
serologically by neutralization tests employing either 
chicken antiserum or a standard reference antiserum. 
According to Marshall and his coworkers (34), the SP 
and LP types were antigenically the same in cross-
neutralization tests with rabbit antisera. Despite 
the reported similarities, Marshall's group did observe 
some apparent differences between the variants. The 
average plaque diameter of the LP variant, in contrast 
to the others, was more markedly reduced in the presence 
of specific antiserum. They also reported that the 
SP variant appeared to be more effectively neutralized 
by either homologous or heterologous antisera, than was 
the LP variant. 
Antigenic variation with serial passage 
Olltsky ^  al. (45) asserted that frequent and 
consecutive intracranial passages in some unknown manner 
caused their stock strain of WEE virus to undergo an 
immunogenic change during the years that it was main­
tained at the Rockefeller Institute. They found that 
mice which had been immunized with several newly isolated 
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strains of WEE virus were unprotected against challenge 
by their stock strain, If a high passage level of this 
strain was used for challenge. The mice were Immune to 
challenge however, with an equivalent dosage of the same 
stock strain If a lower passage level was used as the 
challenging virus. 
Using neutralization, complement-fixation and 
hemagglutlnatlon-lnhlbltlon tests, Karabatsos, Bourke 
and Henderson (28) also noted significant differences 
between newly-Isolated strains and older laboratory 
strains of WEE virus. Since these antigenic differences 
were so great, they avoided classification of the 
Isolates as new arboviruses, only after selective cloning 
procedures demonstrated an Interesting degree of antigenic 
heterogeneity in both the old and new strains. 
Antigenic heterogeneity 
Henderson (21), by selective cloning of ten WEE 
strains, found that most contained sub-populations 
having antlgenically distinct properties. He suggested 
that the quantitative distribution of common but distinct 
antigens determined the Immunological characteristics 
of each strain. Since they existed as mixed populations, 
the antigenic properties of these strains could be 
modified by host selection during serial passage. This 
type of host selection may markedly alter the results 
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of serological tests used to determine WEE virus antigenic 
relationships, according to Satumo and Henderson (52). 
In their latest reported study, Henderson, Shah and Wallis 
(22) detected differences in.the replication rates and 
differences in the rates of release of two antigenic 
subtypes from CE cells in culture. They suggested that 
these rate differences might well account for the host-
selection phenomenon observed in these cells. 
Henderson^ recently stated, "We have not noted 
any consistent variation in plaque size during the 
derivation of distinct plaque antigens from various 
V/EE strains. However, certain unpurified strains do, 
in our hands, consistently produce smaller plaques 
than others. Most certainly a correlation between plaque 
size and antigenic property would be important to 
pursue...". 
^Henderson, J. R., Yale University School of Medicine, 
New Haven, Connecticut. Unpublished observations. Private 
communication. 1965. 
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EXPERIMENTAL PROCEDURE 
Source of Viruses 
Records strain 
This research project was mainly an investigation 
of the properties of three plaque-size variants of the 
Records strain of WEE virus. This strain was originally 
one of seven isolates obtained by Dr. Edward Records 
during an outbreak of encephalomyelitis in horses and 
mules in Churchill County, Nevada, in the late summer of 
1931. The original laboratory passage was in guinea pigs 
inoculated intracerebrally with emulsified horse brain 
tissues. Between 1935 and 1951. the Records strain 
underwent an indeterminant number of chicken embryo 
passages at Port Dodge Laboratories, Port Dodge, Iowa. 
It was first obtained by Dr. R. A. Packer of the Depart­
ment of Veterinary Hygiene, in May of 1951. 
Derivation of the plaque-size variants 
The sole criterion employed for the selective 
cloning of three variants from the Records strain 
was their difference in plaque diameter on CE cell 
cultures. The cloning experiments and the passage 
histories, which differed for each of the variants, 
are outlined in Tables 1, 2 and 3. 
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Table 1. Derivation of the LP variant 
Records strain obtained from Fort Dodge Laboratories 
E 2227 (1951) 
8 serial chicken embryo passages 
E 5231 (1959) 
4 serial passages 
guinea pig kidney cells 
in tube cultures 
GPK 4 (1959) 
initial plaque assay 
CE cell cultures 
TC 161 (predominantly LP, some SP or MP) 
3 serial clonings 
CE cell cultures 
LP selected for repassage 
TC 4a (approximately 99 percent LP) 
5 serial passages 
CE cell cultures 
- 1  
near terminal at 10 
dilution dilution 
TC 13A (95 percent LP) TC 13B (35 percent LP 
^ 65 percent MP) 
7 serial clonings • 
CE cell cultures abandoned 
LP selected for repassage 
LPH (apparently pure LP variant) 
T 2 serial passages CE cell cultures 
LPH-f2 (population referred to as LP Records variant) 
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Table 2. Derivation of the MP variant \ , 
7 ' 
Records strain obtained from Port Dodge Laboratories 
E 2227 (1951) 
8 serial passages 
chicken embryos 
low dilution 
£5231 (1959) 
8 additional serial passages 
chicken embryos 
near terminal dilution 
E 5758 (1961) 
4 serial passages 
weanling mice 
intracranial route 
dilutions unrecorded 
4 E-M (1961) 
4 additional serial passages 
weanling mice 
intracranial route , 
all at low dilution (lO" ) 
11 M first plaqued on CE cells (65 percent MP variant) 
(35 percent SP variant) 
1 passage 
weanling mice 
10 ^  dilution 
11 M-2 replaqued on CE cells (nearly 100 percent MP variant) 
4 serial clonings 
CE cell cultures 
MP selected for repassage 
MP 4a (apparently pure MP variant) T 2 serial passages CE cell cultures 
MP 4A-f2 (population referred to as MP Records variant) 
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Table 3. Derivation of the SP variant 
Records strain obtained from Port Dodge Laboratories 
E 222/. (1951) 
,8 serial passages 
chicken embryos 
low dilution 
E 5231 (1959) 
8 additional serial passages 
chicken embryos 
near terminal dilution 
E 5758 (1961) 
4 serial passages 
weanling mice 
intracranial route 
dilutions unrecorded 
4 E-M (1961) 
4 additional serial passages 
weanling mice 
intracranial route . 
all at low dilution (10" ) 
11 M first plaqued on CE cells (65 percent MP variant) 
, (35 percent SP variant) 
4 serial clonings 
CE cell cultures 
SP selected for repassage 
SPN (approximately 2 percent MP impurity remained) 
T 3 additional serial clonings CE cell cultures SP selected for repassage 
SPR (no detectable MP impurity) 
T 1 passage CE cell cultures, fluid maintenance 
Spy (approximately 2,0 percent MP impurity detected) 
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Recent WEE isolates 
Six first-passage WEE virus isolates were obtained 
through the courtesy of Dr. C. S. Mollohan, Colorado State 
Department of Public Health, and Dr. Louis C. LaMotte 
and Mr. Larry Kirk of the Virus Investigations Unit, 
Disease Ecology Section, U.S. Public Health Service in 
Greeley, Colorado. All six samples were received in 
the form of frozen brain suspensions from suckling mice. 
One additional isolate was kindly supplied by 
Robert H. Kokernot, M.D., Assistant Director of the 
Center for Zoonoses Research, University of Illinois, 
Urbana, Illinois. The sample received was in its 
second mouse brain passage, after 2 initial passages 
in chicken embryos. Table 4 contains a description of 
the source and date of isolation of each virus. 
Cell Culture Techniques 
Routine culture procedures 
In an earlier paper, the author (3) has described 
CE cell culture techniques in detail. With the one 
following exception, identical procedures were used in 
the present study. In previous work, complete cell 
culture media were prepared, and then filter sterilized. 
In this project, cell culture media were autoclaved 
prior to the addition of sterile antibiotics, sodium 
Table 4. Description of seven recent WEE virus isolates 
Identification Original 
number host 
Specimen 
collected 
Geographical 
location 
Date of 
isolation 
65V-241 
65V-796 
65V-6 57 
65V-692 
65V-633 
65V-629 
E 2329 
Passer domesticus 
Passer domesticus 
Culex tarsalis 
Culex tarsalis 
Culex tarsalis 
Culex tarsalis 
3-yea,r-old pony 
whole blood 
whole blood 
Texas 
Texas 
10 mosquitoes Texas 
10 mosquitoes Texas 
July 9, 1965 
August 4, 1965 
July 21, 1965 
July 24, 1965 
50 mosquitoes Colorado July 22, I965 
50 mosquitoes Colorado July 18, I965 
brain Illinois Sept. 11, 1964 
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bicarbonate and bovine serum. Filtration was used 
only for the sterilization of trypsin solutions and 
serum. -
The standard plaque assay 
Unless otherwise specified, all plaque titrations 
were performed under the standard plaque assay con­
ditions. They have also been completely described (3)t 
but a brief summary follows. The CE cell cultures 
were routinely Infected at 48 hours of age. Viruses 
were allowed a period of one hour for adsorption to 
cells before overlays were added. The overlay medium 
consisted of Earle's balanced salt solution, adjusted 
to an Initial pH of 7.6 with sodium bicarbonate. The 
overlays also contained 0.5 percent lactalbumin hydrol-
ysate®, 5.0 percent bovine serum and 0.75 percent Noble 
agar^. Penicillin (100 units per ml.) and streptomycin 
sulfate (100 micrograms per ml.) were included. The 
monolayers were stained with neutral red in a second 
agar overlay. Plaques were routinely counted and 
measured 48 hours after cell culture infection. 
It should be emphasized that the term "standard" 
plaque assay", as it is used throughout the remainder 
of this paper, refers exactly to the entire set of 
^•^Difco Laboratories, Inc., Detroit 1, Michigan. 
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conditions just specified. Because these environmental 
conditions were maintained as constant as possible in 
all experiments, any differences in plaque diameters 
detected were the result of the different properties 
of the three variants, or the result of selected and 
controlled changes in the environment. 
Fluid media and diluent 
For routine virus propagation in CE cell cultures, 
a fluid maintenance medium was employed. This medium 
was identical to that used in agar overlays except for 
the omission of Noble agar. In certain instances to 
be noted later, the bovine serum was also omitted from 
the fluid maintenance medium. This same medium, without 
serum, was also used as a cell culture wash medium, and 
as the diluent for serum or virus. Dilution blanks were 
dispensed from freshly prepared medium in the day they 
were used in order to avoid changes in pH which some­
times occurred with storage. In all the titrations 
reported, separate pipettes were used at each dilution. 
Plaque Diameter Comparisons 
The three Records variants 
During the course of many experiments, there were 
ample opportunities to determine the characteristic 
plaque diameters of the LP, MP and SP Records variants 
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under standard assay conditions. The relative plaque 
size of a virus population remained constant. As a 
result, if a sample of each variant was included in 
J 
each trial, the plaques obtained provided an excellent 
standard of comparison and an indicator of the per­
formance the cell culture system. The degree of 
purity and the stability of the variant populations 
could thus be determined. If any changes in the 
plaque-size properties of a virus population occurred 
or could be induced, they were readily detectable. 
Seven recent WEE virus isolates 
Parallel titrations of seven newly-isolated field 
strains of WEE virus, and of the three Records variants 
were made on cultures grown from the same lot of CE 
cells. The plaque-size properties of each virus population 
were compared using the standard plaque assay procedure. 
Effects of agarose overlays 
According to DeMaeyer and Schonne (14), agar is 
composed of two polysaccharides, agaropectin and 
agarose. It is the agaropectin component which con­
tains most of the sulfate groups normally found in 
agar. Following the method of Porath and HJerten (46), 
an agarose preparation nearly free of negatively-
charged ionizable groups can be obtained from Noble 
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agar. Marine Colloid, Inc., manufactures an agarose^ 
with'less than 0.1 percent sulfate content. Prelim­
inary experiments with this preparation indicated that 
a 0.375 percent concentration of agarose yielded over­
lays of approximately the same consistency as Noble 
agar overlays at the standard 0.75 percent concentration. 
To determine the relative plaque diameters of each 
Records variant in the virtual absence of sulfate inhibitor, 
plaques were compared by the following procedure. 
Duplicate sets of cultures from the same lot of CE 
cells were inoculated with identical samples of the 
LP, MP or SP variant. One set received the standard 
overlay. The duplicate set was overlayed with a medium 
in which agarose (0.375 percent) had replaced the Noble 
agar. Diameters of the resulting plaques were compared. 
Effects of inhibitors added to agarose overlays 
Since agarose overlays are relatively free of 
inhibitors of WEE virus plaque development, their use 
provided the opportunity to directly observe the effects 
on plaque development of known inhibitory substances. 
Before incorporation in agarose overlay medium, several 
additives were prepared in the following way. 
^•Seakem agarose, distributed by Bausch & Lomb, 
Rochester, New York. 
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Suspensions of agarose (0.375 percent), Noble 
agar (0.75 percent) and Bacto agar^ (1.0 percent) in 
distilled, deionized water were autoclaved, allowed to 
cool and solidify in the form of shallow blocks, and 
then were frozen for 24 hours. After the blocks were 
thawed, the fluid which escaped was filtered through 
sterile gauze and centrifuged for 10 minutes at 
1,000 rpm. Each of the resulting supernatant fluids 
(agar extracts) was stored at 5° C. until used. A stock 
solution of sodium dextran sulfate 500^ was prepared 
immediately before use by dissolving 200 mg. in 100 
ml. of sterile, deionized water. 
As before, different sets of CE cultures grovm. 
from the same lot of cells were infected with identical 
sample inocula of the LP, MP or SP variant. As shorn in 
Table 5. only the overlay composition within each set 
was varied, and plaque diameter comparisons were other­
wise made by the standard assay procedure. 
^Difco Laboratories, Inc., Detroit 1, Michigan. 
^Pharmacia, Uppsala, Sweden, 
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Table 5. Variations in overlay composition 
Basal medium Additive Pinal concentration 
Agarose overlay Agarose extract 5.0 percent 
Agarose overlay Noble agar extract 5.0 percent 
Agarose overlay Bacto agar extract 5.0 percent 
Agarose overlay Dextran sulfate 100 mcg/ml. 
Effects of cysteine and lactalbumin hydrolysate In 
skim milk overlays 
To determine the effect on plaque diameters of 
added cysteine or lactalbumin hydrolysate, it was 
necessary to first employ a basal medium containing a 
minimal amount of these ingredients. A skim milk medium 
has been proposed for this purpose by Wallis and Melnick 
(58). The medium used in the present study consisted 
of Earle's balanced salt solution, the usual concentrations 
of antibiotics, 0.1 percent skim milk and 0.75 percent 
Noble agar. It was buffered to an initial pH of 7.6 
with sodium bicarbonate. The skim milk was added from a 
2.0 percent stock solution of instant nonfat dry milk& 
prepared according to the method Rhim and Melnick (50). 
^Carnation Co., Los Angeles, California. 
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In parallel assays on cultures from the same lot 
of CE cells, three variations of the basal medium were 
also tested. In one set of cultures, the skim milk 
medium contained L (+) cysteine monohydrochloride^ in 
2.0 millimolar concentration, added immediately prior 
to use. In a second set, 0.5 percent lactalbumin 
hydrolysate was added. The third variation was the 
substitution of 0.375 percent agarose for Noble agar. 
Plaque diameters of the Records variants under each 
type of overlay were determined. 
Effects of bovine serum 
Control media for this experiment were Noble agar 
and agarose overlays which contained no serum. Test 
media were the same preparations, but with bovine serum^ 
added at a 5.0 percent concentration. The effects of 
the added serum on the plaque development of each 
Records variant were thus determined in the two types 
of overlay medium. 
Bpfanstiehl Laboratories, Inc., Waukegan, Illinois. 
^Grand Island Biological Co., Grand Island, New York. 
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Rates of Virus Accumulation in Cell Culture Medium 
» 
Purpose of experiment 
Independent of the effects of overlay composition, ) 
the rate of increase in plaque size is limited by the 
rate at which newly-synthesized virus accumulates in 
the cell culture medium. This additional factor which 
could possibly affect the plaque-size properties of the 
Records variants was investigated by following the 
procedures outline by Dulbecco and Vbgt (16) for one-
step growth curve experiments with WEE virus on chicken 
embryo cells. 
Experimental procedure 
Cultures grown from the same lot of cells were 
placed in three groups. Each group was inoculated with 
one of the three Records variant populations. The 
multiplicity of infection was estimated to be between 
5.0 and 10.0, so that nearly all susceptible cells in 
each culture would be initially infected. After 30 
minutes for virus adsorption, the cultures were washed 
twice. Five ml. of fluid maintenance medium were then 
added to each culture, and zero-time samples of the 
medium were immediately taken from two cultures in each 
- group. The remaining cultures were returned to the 
incubator. During the subsequent 18-hour incubation 
period, additional duplicate samples of maintenance 
' r ' 
medium were harvested from two cultures in each group 
at two-hour intervals. All samples were immediately 
frozen at -40° C. until they could be titrated for virus 
content. 
Multiplicity of infection 
To determine the actual multiplicity of infections, 
the three test inocula were each further diluted for 
titrations by the plaque technique on additional cultures 
from the same lot, Prom these titrations, the titer 
of each Records variant used in the experiment was 
determined to be as follows: LP = 1.60 x 10^, MP = 
3.84 X 10^, and SP =9.55 x 10® plaque-forming-units 
(PFU) per ml. 
The cells from 12 uninfected, cultures were used 
for separate direct cell counts, and the average of the 
12 counts became the estimated over-all average number 
of cells per culture. After growth medium was removed, 
1.0 ml. of a solution of Versene®' (ethylene diamine 
tetra acetic acid tetra sodium dihydrate, 1:2,000) and 
trypsin^ (0.2 percent) in phosphate buffered saline was 
added to each plate. Each suspension of released cells 
was Immediately diluted 1:10 in standard diluent. After 
^Nutritional Biochemicals Corp., Cleveland 28, Ohio. 
^Difco Laboratories Inc., Detroit 1, Michigan . 
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mixing, a sample of each diluted cell suspension was 
counted in a hemocytometer. The counts varied from 
3.7 X 10^ to 4.9 X 10^ cells, giving ah average of 4.2 
6 
X 10 cells per culture. 
The multiplicity of infection with each variant 
was calculated by dividing the number of PFU in each 
inoculum by the average number of cells per culture. 
These values were as follows: LP = 1.90, MP = 4.53, 
and SP =11.33. f 
Determination of results 
The virus titer of each maintenance medium sample 
was subsequently determined by the standard plaque assay 
procedure. Therefore the plaque-size properties of the 
virus which accumulated could also be determined. 
Virulence Comparisons 
Virus preparations 
Plaque-cloned populations of each Records variant 
were propagated in CE cell cultures. When cytopathic 
effects were nearly complete, the viruses were harvested 
by removal of the fluid maintenance medium. Stock pools 
of each variant were dispensed in 2.5 ml. aliquots and 
frozen at -40° C, until titrations in several hosts 
could be performed. 
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Plaque titrations 
Aliquots from each pool were titrated by the standard 
plaque assay. Both the titers (expressed as PFU per ml.) 
and the plaque-diameter distributions were compared. 
Virulence for chicken embryos 
Each Records variant was titrated, using five embry-
onated hens' eggs® per virus dilution. The procedure for 
intra-allantoic inoculation of ten to 11-day-old chicken 
embryos has previously been described (3). The relative 
virulence of each variant for the embryos was determined 
by comparing their infective titers (LD^g per ml.). Fifty 
percent endpoints were estimated, as in all subsequent 
titrations, by the method of Reed and Muench (4?). 
Virulence for baby chicks 
Each Records variant was titrated in baby chicks 
by subcutaneous inoculation of 0.1 ml. of each virus 
dilution. Groups of five half-day-old chicks^ injected 
with each dilution were separately housed in hatchery 
shipping cartons placed within modified Horsfall-Bower 
stainless steel isolation units. The inoculated chicks 
®'^Embryonated eggs and baby chicks were provided 
by Dr. M. S. Hofstad, Veterinary Medical Research Institute, 
Iowa State University, Ames, Iowa. 
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were fed, watered and observed at 12-hour intervals, 
and dead chicks were removed. The cardboard shipping 
cartons and their contents were incinerated, and the 
units were disinfected after each successive trial. 
The infective titer (LD q^ per ml.) of each Records variant 
was determined. Samples of virus reisolated from the 
brains of moribund chicks after infection with the Impure 
SP inoculum were later assayed by the standard plaque 
technique. 
Virulence for mice 
Weanling mice, obtained from Slmonsen Laboratories. 
Inc., White Bear Lake, Minnesota, were separately caged 
in groups of five mice each. The mice Inoculated with 
the Records variants by the intraperitoneal route received 
0.1 ml. doses of virus. Those injected Intracranlally 
were each given 0.03 ml. The mice were observed daily 
until no further deaths attributable to the virus oc­
curred. The titer (LD^^ per ml.) of each variant by 
each route on inoculation was calculated. 
Comparison of Antigenic Properties 
Identification of the Records variants 
It was necessary to Identify each of the variants 
as WEE virus, and also necessary to prove that none of 
them was a contaminating virus accidentally obtained 
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during the serial passages of the Records strain in 
guinea pig kidney cell cultures or in mice. , For this 
purpose, anti-WEE, anti-EEE and anti-SLE typing sera were 
obtained from the Communicable Disease Center, U. S. Pub­
lic Health Service, Atlanta, Georgia. Serum samples were 
also collected and pooled from two young roosters after 
each had been infected with a plaque-purified LP variant 
inoculum (1.0 ml., containing 2.0 x 10^ PFU). The 
specificity of these four antisera for each of the Records 
variants was determined by a virus neutralization test, 
performed by a procedure which will later be described. 
Preparation of inactivated Records variant antigens 
Plaque-cloned populations of each Records variant 
were propagated in CE cell cultures, using serum-free 
maintenance medium. The medium was collected from each 
set of infected cultures when cytopathic effects were 
nearly complete, and also at this time from a set of 
uninfected control cultures. Cellular debris was sedi­
ment ed from each fluid pool by centrifugation at 1,000 rpm. 
for 20 minutes. Several 2.5 ml. aliquots of each of the 
resulting supernatant fluids were immediately frozen. 
The remaining supernatant fluids were used for antigen 
preparation. To each, 10 percent formalin was added in 
amounts sufficient to produce a final 0.2 percent 
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concentration. The resulting LP, MP, SP and control 
o 
antigens were stored at 5° C. for two weeks prior to 
their Initial use. 
Guinea pig immunization 
Each of the four antigens was injected into three 
young adult guinea pigs, according to the time schedule 
shown in Table 6. 
Table 6. Immunization and bleeding of guinea pigs 
Days 
elapsed 
Antigen®" 
dosage 
Route of 
inoculation 
Blood^ 
collected 
0 0.2 subcutaneous none 
7 1.0 subcutaneous none 
14 2.0 intraperitoneal 5.0 
35 none none 10.0 
^'Milliliters, to each guinea pig. 
^Milliliters from each, by cardiac puncture. 
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Guinea pi.s: ant 1 sera 
After each bleeding, the sterile serum from each 
group of three guinea pigs was pooled, and identified 
as LP, MP or SP antiserum or control serum. Each pool 
was then frozen. Serum neutralization tests were per-
• formed with the 14-day sera only.. Samples from both 
l4-day and 35 day bleedings were titrated by hemagglutination-
inhibition tests. 
Neutralization tests 
So that plaques could be readily counted after 
the performance of serum neutralization tests, it was 
essential that each control culture (from the set 
inoculated with a 1:1 mixture of control serum and virus) 
should receive approximately 50 PPU of virus. After 
samples of each Records variant were titrated by the 
standard plaque assay, similar samples were sufficiently 
diluted so that each contained an estimated 200 PFU 
per ml. Thus, after mixing of a 1.0 ml. aliquot with an 
equal volume of control serum, the desired number of virus 
particles was contained in 0.5 ml. of inoculum. 
Before testing, each serum sample was heated to 
inactivate complement, and then initially diluted 1:10. 
Serial master dilutions in five-fold steps through 
1:1250 were then made, and 1.0 ml. aliquots of each 
dilution were dispensed into separate tubes before 
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addition of virus. 
The serum and virus mixtures (2,0 ml. total volume) 
were incubated for 30 minutes at room temperature. At 
the end of this time, unneutralized virus was titrated 
by. three replicate platings (0.5 ml. each) from each test 
mixture on CE cell cultures. The standard plaque assay 
procedure was used. 
All neutralization tests had thus been performed 
by the beta procedure, using constant amounts of each 
Records variant and testing against serial five-fold 
antiserum dilutions. The resulting antiserum titers 
were expressed as the reciprocal of that dilution which, 
in comparison to the average result with all control 
serum dilutions, caused a 50 percent reduction in the 
number of counted plaques. 
Hemagglutination tests 
Hemagglutination (HA) tests were performed by 
following essentially the same procedures as those 
described by Clarke and Casals (8). The borate-
buffered saline (BBS), the phosphate-buffered saline 
(PBS) and the acid-citrate-dextrose (ACD) solutions 
used in the tests were prepared according to their 
suggested formulas. Only the points of departure from 
their widely-accepted standard procedures will be described. 
Plaque-cloned populations of each Records variant 
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were propagated in CE cell cultures, using serum-free 
maintenance medium. Cultures were washed twice with 
serum-free diluent prior to inoculation with virus. 
Each virus was harvested when cytopathic effects in 
the cultures were nearly complete. Cell debris was 
sedimented from the medium harvested from infected 
cultures by centrifugation at 1,000 rpm. for 20 minutes. " 
Samples of each supernatant fluid were frozen for later 
plaque titrations. Additional samples were diluted 
1:10 in BBS at pH 9.0, and stored at 5° C. for later 
use as HA test antigens. Further 2-fold dilutions of 
each antigen in BBS were made prior to each test. 
Erythrocytes used in the HA test were obtained 
by bleeding day-old chicks into physiological saline 
solution containing 0.4 percent sodium citrate. The 
cells were immediately sedimented and resuspended In 
ACD solution for storage at 5° C. Just before use, 
they were washed three additional times in ACD solution. 
Pinal suspension was in a PBS solution with phosphate 
buffer concentrations appropriately chosen so as to 
establish a final pH of 6.0 after mixing of cells and 
virus. The concentration of red blood cells in the 
resulting suspension was 0.25 percent, based on packed 
cell to total fluid volume. 
The test was performed by mixing 0.5 ml. of each 
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antigen dilution with an equal volume of suspended cells 
and incubating for two hours at room temperature. Tests 
were read at this time by observing the tube containing 
the highest virus dilution in which complete hemagglutination 
had occurred. One HA unit was designated as the smallest 
amount of virus antigen required to completely agglutinate 
the standard amount of chick erythrocytes under the 
conditions described. 
Hemagglutination-Inhibition test 
Samples of each pooled guinea pig serum were prepared 
for use in the hemagglutination-inhibition (HI) test by 
following the adsorption procedures described by Clarke 
and Casals (8). Non-specific inhibitors of hemagglutination 
were adsorbed with kaolin^. Naturally-occurring agglutinins 
for chicken erythrocytes were then adsorbed by treatment 
with packed, washed red blood cells from day-old chicks. 
Starting with an initial 1:10 dilution, serial 2-fold 
dilutions of each serum were made. Aliquots (0.25 ml.) 
of each were then dispensed into separate tubes for 
addition of antigen. 
To each serum dilution, 0.25 ml. of virus antigen, 
sufficiently diluted in BBS so as to contain 4 HA units, 
was added. Serum and virus mixtures were Incubated 
&Jay E. Cook, Importer, Cockeysville, Maryland. 
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overnight at 5° C. prior to the addition of 0.5 ml. 
of a 0.25 percent suspension of chick erythrocytes. 
Subsequent incubation and reading of the tests was by 
the procedure described for hemagglutination. 
Antiserum titers were expressed as the reciprocal 
of the highest dilution causing complete inhibition of 
hemagglutination, under the conditions described. 
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RESULTS 
Plaque Diameter Comparisons®" 
The parent strain 
A"sample of the Records strain of WEE virus, which 
had been kept frozen in chicken embryo allantoic fluid 
for 15 years, was titrated by the standard plaque assay 
procedure. Its titer, after storage for that length of 
q 
time, was 2.2 x 10" PFU per ml. The plaques ranged in 
size from 2.0 to 5.0 mm.,- and the mean plaque diameter 
was 3.9 mm. This then, was the characteristic plaque 
size of the Records strain as it existed in 1951» before 
any selective cloning experiments were performed. 
Results of selective cloning 
The typical appearance of plaques produced by each 
of the Records variants in CE cell cultures under stand­
ard assay conditions is shown in Figure 1. Each type 
of plaque may be clearly distinguished from the others 
on the basis of size. 
Also after titration by the standard assay procedure, 
the range in size and the mean plaque diameter of each 
of the Records variants can be graphed as in Figure 2. 
Differences between the mean plaque diameters were tested 
for significance by the T-test following the method 
^Complete data may be found in the Appendix. 
Typical appearance of plaques produced by 
each of the Records variants under standard 
plaque assay conditions 
LP variant 
MP variant 
SP variant 

Pi^re 2. Plaque diameter range and mean of each 
Records variant under standard conditions 
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of Snedecor (53)f and were found to be significant 
at the 99 percent level of probability. 
The MP variant produces plaques very closely 
approximating the diameter of those produced by the 
parent virus. As it was used in the current study, 
the MP variant was apparently a plaque-purified, 
population after having undergone four serial clonings 
in CE cell cultures. 
The LP variant was detected for the first time 
after a sample of the Records strain had been serially 
passed in guinea pig kidney cell cultures. As 
previously reported (3), there was evidence that it 
existed as an incompletely purified population after 
three serial selective clonings. It was purified 
however, as a result of seven additional serial clonings 
and it was an apparently pure LP population which was 
investigated in the project being reported. 
The SP variant first appeared in a sample of the 
Records strain which had undergone eight serial intra­
cranial passages in weanling mice. It has thus far 
been impossible to plaque purify SP variant populations 
by selective cloning in CE cell cultures. The presence 
of a MP impurity at a level of one to two percent of the 
total plaques counted was a consistent finding when 
selectively-cloned SP populations were titrated. 
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•J Properties of seven recent WEE virus Isolates 
The range In size and the mean plaque diameters of 
seven recent WEE virus Isolates, and those of the three 
Records variants are compared In Figure" 3» The field 
strains tested were Isolated In several states and from 
several different host species. It can be seen that the 
mean plaque diameter of each recent Isolate was not far 
different from that of the LP variant. However there 
was usually a broader size range, and nearly every 
Isolate produced some plaques resembling the MP type. 
In no case, were small plaques observed. 
Several of the field strains produced plaques which 
appeared to fall Into tw^ distinct size groupings. This 
result is indicated in Figure 3 by the bar graphs of 
plaque-size distribution which contain central unshaded 
segments. Additional evidence for this apparent plaque-
size heterogeneity was obtained as a result of a second 
CE cell culture passage, since the progeny virus harvested 
from either large or medium-type plaques again produced 
plaques ranging widely in size and again consisting 
mostly of the LP type. The rather limited trials did 
not result in the selective cloning of a MP variant from 
any of the field strains. 
Figure 3. Comparison of the plaque diameters of seven recent isolates 
with those of the Records variants 
Letters designate the strains and sources of isolation as follows: 
L. Records strain, LP variant 
M. Records strain, MP variant 
S. Records strain, SP variant 
A. 65V-2^1, whole blood, Passer domesticus, Texas 
B. 65V-796, whole blood. Passer domesticus. Texas 
C. 65V-657, Culex tarsalis pool, Texas 
D. 65V-692, Culex tarsalis pool, Texas 
E. 65V-633. Culex tarsalis pool, Colorado 
P. 65Vt629, Culex tarsalis pool, Colorado 
G. E 2329, pony brain, Illinois 
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Effect of agarose overlays 
The typical mean plaque diameter of each of the 
Records variants was increased when these viruses were 
titrated under overlays containing agarose in place of 
Noble agar. The relative magnitude of this increase 
is graphed in Figure 4. The percent increase in mean 
plaque diameter is also indicated, but is not graphically 
represented. 
The LP variant, known to be relatively insusceptible 
to the effects of the agar inhibitor, therefore exhibited 
the smallest plaque-size increase when inhibition was 
removed. Under overlays with reduced sulfate ion content, 
the MP variant produced plaques with an average diameter 
that surpassed even the LP type. The percent increase 
in diameter was greatest for the SP type, but the actual 
mean plaque diameter attained fell far short of this value 
for the other variants. As a result, the difference in 
size between small and medium plaques became even more 
distinctly observable under agarose overlays. Some other 
limiting factor, in addition to sulfated-polysaccharide 
inhibition apparently was responsible for restricting 
the development of plaques produced by the SP variant. 
Differences between the mean plaque diameters of 
each variant under agarose overlays were also found to 
be significant at the 99 percent level of probability. 
Figure 4. Relative increase in pl&que diameters resulting from the 
^substitution of agarose for Noble agar in the overlay medium 
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when tested by the method of Snedecor (53). 
Effect of Inhibitors added to agarose overlays 
Various preparations containing sulfated poly­
saccharides were added to agarose overlay medium. 
Titration of each Records variant under each type of 
overlay yielded the results shown in Figure 5. The 
vertical arrows.indicate the amount of change in the 
mean plaque diameter that can be attributed to each 
added preparation. 
The characteristic plaque size of each variant 
under agarose control overlays (A) was initially com­
pared. The addition of Noble agar extract (B) caused 
a reduction in the size of plaques produced by the MP 
and SP variants without noticeably decreasing the mean 
plaque diameter of the LP type. In the presence of 
Bacto agar extract (C), small and medium plaques were 
further reduced in size. A reduction in the average 
plaque diameter of the LP variant did occur, but to 
a lesser degree. A significant decrease in the average 
plaque size of all the variants was observed in the 
presence of the overlay medium containing 100 micrograms 
of sodium dextran sulfate per ml. (D). Under this type 
of overlay, differences in plaque diameter between the 
three Records variants were virtually non-existent. 
Figure 5. Effect on plaque diameters of Inhibitory substances added to 
agarose overlays 
Letters Indicate the following preparations: 
A. Agarose extract 
B. Noble agar extract 
C. Bacto agar extract 
D. Sodium dextran sulfate 
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Effects of cysteine and lactalbumln hydrolysate added 
to skim milk overlays 
Figure 6 is a graph of the plaque diameter range 
and mean of each variant determined by titrations under 
skim milk overlays with various modifications. The 
increase in mean plaque diameter which resulted from 
each modification of the basal overlay medium is illus­
trated by a vertical arrow. 
The bar graphs in group A indicate the plaque-size 
properties of each variant under a basal skim milk 
overlay containing Noble agar and no additives. The 
smaller-than-usual plaques (smaller than those produced 
by the three variants under standard assay conditions) 
were apparently not the result of deficient nutritive 
properties of the skim milk maintenance medium.- This 
fact was established by the observance of the significantly 
larger plaques (D) which were produced in the same skim 
milk medium changed only by substituting agarose for 
Noble agar. 
The addition of cysteine to skim milk and Noble 
agar overlays (B) caused an increase in the average 
diameter of each type of plaque. It also was observed 
(as may be seen from a comparison of the mean plaque 
diameters graphed in groups A and B of Figure 6) that 
the relative increase was greatest for the LP variant. 
Figure 6. Relative increase in plaque diameters resulting from changes 
in the composition of skim milk overlay medium 
Letters indicate media of the following compositions: 
A. Skim milk with Noble agar 
B. Skim milk with Noble agar plus cysteine 
C. Skim milk with Noble agar plus lactalbumin hydrolysate 
b. Skim milk with agarose 
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Lactalbumin hydrolysate, when added to skim milk 
and Noble agar overlay medium (C), was responsible for 
a further increase in plaque size. The range in plaque 
size for each variant under this type of overlay was ' 
nearly identical to that typically observed under the 
standard plaque assay conditions. The LP variant, in 
the skim milk, lactalbumin hydrolysate and Noble agar 
medium, produced plaques with a mean diameter nearly 
equal to those which it produced under agarose overlays. 
It can be noted in Figure 6 (C and D) that this was not 
the case with the MP and SP variants. Only a relatively 
small increase in the medium and small plaque types re­
sulted from the addition of lactalbumin hydrolysate. 
Effects of bovine serum 
The effect of bovine serum in the overlay medium 
has been found to vary, depending upon the variant 
titrated and upon whether agarose or Noble agar overlays 
were used. These different effects on plaque development 
are shown in Figure 7. As in previous graphs, the arrows 
are used to indicate the amount of increase or decrease 
in the mean plaque diameter of each variant. 
As indicated in Figure 7, there was little, if any, 
change in the mean plaque diameter of the SP variant 
when serum was added to either Noble agar or agarose 
overlay medium. In either medium, 5 percent bovine serum 
Figure 7. Relative changes in plaque diameters resulting from the addition 
of bovine serum to Noble agar or agarose overlays 
Letters indicate the following: 
A. Noble agar overlay without serum 
B. Noble agar overlay with added bovine serum 
C. Agarose overlay without serum 
D. Agarose overlay with added bovine serum 
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slightly inhibited the development of medium type plaques. 
The results with the LP variant presented still another 
variation. In this case, development of large plaques 
was enhanced by serum under Noble agar overlays, but was 
inhibited by serum under agarose. A possible reason for 
these different results will be discussed. 
Effect of CE cell culture passage on the SP variant 
While the plaque-cloned populations of either 
the LP or MP variant were not observed to change sig­
nificantly during as many as four serial passages in 
CE cell cultures, this has not been true of the SP 
variant populations thus far obtained. In Figure 8, 
an example of typical results obtained with serial 
cell culture passage of a SP population is shown. 
The original population (SPN), after 3 serial 
clonings in CE cultures, produced primarily small 
plaques, 77 percent of which were 1.0 mm. or smaller 
in diameter. Only 2 percent (shown as the first darkly 
shaded bar in Figure 8) were over 2 mm. In diameter, 
and thus fell Into the MP range. After two serial 
passages In CE cell cultures using fluid maintenance 
medium (SPN Fl-1 and SPN Pl-2), the resulting population 
was found to produce approximately 46 percent medium 
plaques (again demonstrated by the darker shading). 
The growth rate study which follows, was initiated as 
Figure 8. Progressive increase in the proportion of 
medium plaques resulting from two serial 
• • cell culture passages of a SP population 
Letters identify the passage levels as follows: 
SPN. Nearly pure SP population resulting 
from three serial clonings 
SPN Pl-1. SPN population after 1 cell culture 
passage 
SPN Pl-2. SPN Pl-1 population after 1 additional 
cell culture passage 
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an attempt to determine a possible cause for this rapid 
increase in the proportion of the MP variant which 
accompanied cell culture,passage. 
* 
Rates of Virus Accumulation in Cell Culture Medium 
Total free virus 
After infection of separate groups of CE cell 
cultures with the Records variants, samples of the 
fluid maintenance medium from each group of infected 
cultures were harvested at 2-hour intervals. The titer 
of accumulated virus in each sample (expressed as the 
Log^Q FPU per ml.) was determined, and was plotted 
versus time in Figure 9. The virus growth curves, as 
drawn, indicate only the total virus titrated, and do 
not take into consideration the plaque types observed 
on the titration plates. 
Populations of the LP and MP variant have been 
successfully plaque-purified as a result of selective 
cloning. The rates of accumulation of these two variants 
could therefore be studied in this experiment by using 
plaque-purified inocula, and the plaques observed on the 
cultures used to titrate accumulated virus were either 
100 percent large or 100 percent medium type plaques, 
depending on the inoculum used. The results obtained 
Çigure 9. Titers of virus accumulated in the fluid 
maintenance medium of cell cultures at 
intervals following infection 
Letters indicate the following: 
L. Pure LP variant 
M. Pure MP variant 
8-M. SP variant, with 4.6 percent MP impurity 
in inoculum 
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with these two variants can therefore be directly com­
pared and analyzed. The growth rate curves for the 
pure LP and pure MP variants are thus depicted as solid 
lines and closed points in Figure 9. 
In contrast, it has not been possible to obtain 
pure populations of the SP variant. As a result, it 
should be noted that the SP variant preparation used 
as the inoculum in this experiment contained a MP variant 
impurity which was determined to approximate 4.6 percent 
of the total population. When many medium-sized plaques 
appeared on the cultures inoculated with this set of 
maintenance medium samples, it became obvious that this 
impurity in the SP inoculum was of some significance. 
Since curve S-M, as depicted in Figure 9. results only 
from considering total accumulated virus, it is not a 
valid indication of the true growth rate of the SP variant. 
Instead, it represents the combined total of medium and 
small plaques which resulted from a mixed infection. 
Since this result cannot validly and directly be compared 
with those obtained for the other two variants, curve 
S-M is drawn with open points connected by a broken line 
in order to distinguish it from the other curves, and to 
indicate that results from this set of titrations will 
be analyzed independently. 
70 
Rates of accumulation of the LP and MP variants 
Again, in reference to Figure 9, it can be observed 
that the period of most-rapid increase in accumulated virus 
was from 2 to 8 hours post-infection with either the LP or 
MP variant.. By linear regression analysis, best-fitting 
straight lines could be superimposed on this relatively 
linear portion of each curve, as has been done in Figure 10. 
The slope of each line was taken as the best numerical 
estimate of the maximum rate of accumulation of each 
variant. The slope of line M (MP variant) is 0.78 and 
that for line L (LP variant) is 0.75# when calculated by 
the method of Snedecor (53). There is therefore a good 
indication that the rate of accumulation of the MP variant 
only slightly exceeds that of its LP counterpart as a 
result of separate cell culture infections with plaque-
purified preparations. 
Plaques observed after mixed SP-MP cell culture infection 
When the plaques obtained from the SP growth curve 
experiment were classified according to diameter, the MP 
type as a percent of the total counted plaques could be 
plotted, as shown in Figure 11. While the MP impurity 
amounted to only 4.6 percent of the inoculum, It represented 
7.5 percent of the free virus recovered at 2 hours after 
infection. Somewhat surprisingly, this figure rose to 
86.0 percent of the plaques counted from samples taken 
f • 
•c 
Figure 10. Relative rates of accumulation of the LP 
and MP variants in the fluid medium of cell 
cultures following separate infections with 
plaque-purified inoculua 
Solid line M-M represents MP Records variant 
Broken line L-L represents LP Records variant 
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Figure 11. Medium plaque variant, as a percent of the 
total virus, accumulating in the fluid 
maintenance medium of cell cultures after 
infection with an impure SP inoculum 
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at 10 hours post-infection. This result suggested that 
the respective rates of accumulation of the MP and SP 
variants in this set of cultures should be more critically 
compared. 
Rates of accumulation of MP and SP variants 
Using the data already obtained, separate curves 
could be plotted for the MP and SP variants as each 
accumulated in cell culture maintenance medium following 
a mixed infection. They are illustrated in Figure 12. 
As expected, the two curves gave further indication of 
the difference in the rate of accumulation of each variant. 
As was observed in the case of infection with the plaque-
purified variants, the period between 2 and 8 hours 
post-infection was the time of most-rapid increase in 
newly-replicated virus. Best-fitting straight, lines could 
again be employed to estimate the rate differences between 
the variants. The slope of line M (MP variant) is 0.69, 
while that of line S (SP variant) is only 0.42, when both 
are calculated by the previously indicated method, and as 
they are drawn in Figure 13. It was apparently impossible 
to determine tfie actual rate of accumulation of the .SP 
variant which might have resulted from cell culture 
infection with a plaque-purified preparation. It has 
at least been established however, that following a 
mixed SP-MP infection, the MP variant accumulates in the 
Figure 12. Titers of SP and MP variants accumulating 
In the fluid maintenance medium of cell 
cultures following Infection with an 
Impure SP Inoculum 
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Figure I3. Relative rates of accumulation of the SP 
and MP variants In the fluid medium of 
cell cultures following Infection with 
an impure SP inoculum 
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cell cultûre médium at a significantly higher rate. 
Possible homologous interference ' 
One additional rate comparison may' be made when 
I 
the results of the growth rate experiments are considered. 
It may be seen that the estimated rate of accumulation 
for the MP variant was initially 0,78, a value obtained 
from the results of cell culture infection with a plaque-
purified MP inoculum. However, its estimated rate of 
accumulation after a mixed infection of cell cultures 
was calculated to be only 6.69. It is quite likely that 
the presence of the SP variant, and its interference with 
the replication of the MP variant could account for the 
rate differences observed. 
Virulence Comparisons 
Plaque titrations 
The virus titer and the plaque-size properties 
of samples from each pool prepared for the virulence 
trials were determined by the standard plaque assay 
procedure before animal inoculations were begun. The 
titer of each Records variant was as follows; LP = 4.3 
X 10®, MP « 1.5 X 10^ and SP = 3.4 x 10® PPU per ml. 
Since their titers were similar, approximately equal 
doses of each variant could be given to the test animals 
by preparing 'Identical dilutions of each Record variant. , 
» 
The LP'and-the MP populations produced 100 percent large 
and medium plaques respectively, since the selective 
clonl4ig attempts had successfully resulted in the plaque-
purification of these two variants. However, approximately 
1.6 percent of the plaques observed after titration of 
the sample from the SP pool fell into the medium plaque 
• 
size range, indicating once again that complete plaque-
purification of the SP variant population-had not been 
accomplished. Since this was about the highest degree 
of purity obtainable with a SP preparation after prop­
agation in CE cell cultures, it was decided to proceed 
with virulence trials using this SP preparation. 
Virulence for chicken embryos 
Usually at 12-hour intervals following the 
inoculation of embryonated eggs with the three variants, 
50 percent endpoints were calculated. These values 
were then used for plotting the embryo death curves 
for each variant, as shown in Figure 14, It may be seen 
that both the LP and MP variants (L and M respectively) 
caused rapid embryo deaths, and were of approximately 
equal virulence. In contrast, a fifty percent endpolnt 
was not reached with the relatively pure SP variant (S). 
Figure 14 includes, in addition, the results (S-M) 
of a titration of a mixed population of MP and SP variants, 
Comparative virulence of the Records variants 
for chicken embryos' 
f 
Letters indicate the following: 
L. Pure LP variant 
M. Pure MP variant 
S. SP variant (1.6 percent impurity) 
S-M. Mixed population (SP:MP = 1:1) 
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present in approximately equal^proportion. The total virus 
titer (MP and SP variants combined) equalled 2.4 x 10® PFU 
per ml. when this mixed population was titrated in CE cell 
cultures. Therefore the total virus given to the embryonated 
eggs was nearly equal to that given in the pure MP inoculum. 
Prom the pure MP titration, 1.0 LD^g was determined to 
contain 10^*®® PFU of MP variant. If given alone, and 
not mixed with the SP variant, 1.2 x 10® PFU should have 
equalled at least lO^*-^® LD^g and not lO^'^O as actually 
titrated for the combined SP and MP variant inoculum. 
Clearly, the addition of an equal quantity of the SP 
variant was responsible for reducing the titer of the MP 
inoculum, and certainly did not enhance its infectivity. 
Virulence for baby chicks 
In Figure 15, time-death curves similar to those 
in Figure 14 are shown. These resulted from the deter­
mination of virulence of each Records variant for 12-
hour-old chicks. By comparing curves M and L (MP and LP 
variants, respectively) with curve S (SP variant), it 
will be readily observed that a marked difference in 
virulence existed. Not only were there differences 
in the final endpoint titers, but also differences in 
the time at which the endpoints were reached. 
As it appears in Figure 15, curve S is drawn so 
Figure 15. Comparative virulence of the Records variants 
for baby chicks 
Letters Indicate the following: 
L. Pure LP variant 
M. Pure MP variant 
S. SP variant (1.6 percent MP impurity) 
96 
10 
D a y s  P c  s t  - I  n o c u I  a t i o n  
37 
as to Include the deaths of all chicks inoculated with 
the SP variant inoculum. This may misrepresent the 
results actually obtained and give the impression that 
the SP variant possessed greater virulence for baby 
chicks than was actually the case. Of significance 
once again is the fact that the SP inoculum contained 
1.6 percent MP variant as an impurity. Reisolation of 
WEE virus from the brains of infected chicks yielded 
apparently pure MP variant, and no small plaques were 
detected by standard plaque assays of emulsified chick 
brain material. 
Virulence for mice 
Similar time-death curves resulting from titrations 
of the Records variants in weanling mice are graphed in 
Figure 16. Results from both intraperitoneal and intra­
cranial routes of injection are included. 
By the intracranial route, the relative virulence 
of the three variants was not strikingly different, 
especially if the respective titers (PPU per ml.) of 
the three inocula by cell culture titrations are con­
sidered. 
A significant difference between the variants was 
detected however by the intraperitoneal titrations. By 
this route, the virulence of the LP and MP variants was 
Figure l6. Comparative virulence of the Records variants 
for weanling mice 
Letters indicate the following: 
L. Pure LP variant 
M. Pure MP variant 
S. SP variant (1.6 percent MP impurity) 
I.e. Intracranial route of injection 
I.P. Intraperitoneal route of injection 
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still nearly identical, but the SP variant caused no deaths 
and no apparent signs of infection in mice, in spite of the 
presence of the MP impurity in the preparation used as ^ 
ino culum. 
Summary of results 
For a better analysis of the results obtained in the 
virulence trials, they are again presented in composite form 
in Figures 17 and 13. In both figures, the final titer of 
each variant in each host may be directly compared with its 
respective cell culture titer. 
It should be noted in Figure 17, that the titer of the 
SP variant in day-old chicks is again graphed as if it alone 
had been responsible for all of the deaths observed. There 
is reason to believe that the SP variant, if it could be com­
pletely purified, would possess little if any virulence for 
baby chicks. At least some of the deaths indicated were due • 
to the presence of the MP impurity in the SP variant inoculum. 
Comparison of Antigenic Properties®* 
Identification of the Records variants 
Anti-LP and anti-WEE typing serum were found to have 
nearly the same virus neutralization titers (see Figure 19) 
when each was used in neutralization tests with the three 
^Complete data may be found in the Appendix. 
Figure 17. Comparative titers of the Records variants determined by-
parallel titrations in cell cultures, baby chicks and 
chicken embryos 
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Figure 18. Comparative titers of the Records variants determined by-
parallel titrations in cell cultures and in mice by 
intracranial (I.e.) and intraperitoneal (I.P.) routes 
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Figure 19. Neutralization of the Records variants by an ant1-LP serum 
from chickens, and by three arbovirus typing sera 
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Records variants. The. results presented in Figure I9 also 
indicate that there was a limited cross-reaction between 
the variants and the anti-EEE and anti-SLE typing sera. 
However, since all three variants were neutralized at 
significantly higher titers by the two homologous sera, 
they were all identified as WEE virus. 
Reciprocal cross neturalization tests 
Neutralization tests were performed with each Records 
variant using anti-LP, anti-MP and anti-SP antisera pre­
pared by immunization of guinea pigs. The test results 
were derived by accumulating and averaging the data from 
two replicate experiments. 
It may be seen in Figure 20 that each antiserum 
exhibited its highest titer when tested against its homologous 
plaque-type antigen. Thus a degree of plaque-type specificity 
was possessed by each. This was especially true in the 
case of the anti-SP serum, since marked differences in 
its titer resulted from tests with the SP variant in 
comparison to those with the MP and also the LP variant. 
In contrast, the greatest degree of cross-reactivity was 
demonstrated with the anti-LP and anti-MP serum samples. 
Hemagglutination (HA) tests 
Propagation of WEE virus in CE cell cultures was 
apparently a quite satisfactory method of producing an 
Figure 20. Reciprocal cross neutralization of the Records variants 
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HA antigen. The only difficulty encountered in the 
preparation of cell-culture-derived antigens was caused 
by traces of bovine serum which remained in the antigens 
if cell cultures were not thoroughly washed free of growth 
medium (containing serum) before the viruses were inoculated. 
These traces of serum markedly inhibited hemagglutination 
of chick erythrocytes by the three Records variant antigens 
especially at the low antigen dilutions. In the absence 
of the bovine serum inhibitor, readable and reproducible 
HA test results were readily obtained. 
Using this method of antigen preparation, there was 
apparently no advantage to be gained by treating the 
virus preparations with Genetron (trifluorotrichloro-
ethane) as suggested by Karabatsos (26, 27). Nearly 
identical test results were obtained with each of the 
antigens regardless of whether Genetron treatment had or 
had not been used. Apparently Genetron treatment was 
of no value in the attempted removal of bovine serum 
residues from those antigen preparations in which it 
was present. 
Erythrocytes obtained from day-old chicks were 
used with satisfactory results. Under the same test 
conditions, cells from adult chickens or from sheep 
were not agglutinated. . Goose erythrocytes were not 
readily available and were not used. 
101 
An unexplained result was observed in one experiment 
in which sodium dextran sulfate (100 micrograms per ml.) 
was added to the BBS diluent. If present by themselves, 
neither virus nor dextran sulfate caused hemolysis of chick 
erythrocytes, but quickly hemolyzed cells in tubes where the 
dextran sulfate and virus combination was present. With a 
constant concentration of dextran sulfate, progressively 
less hemolysis was observed with increasingly higher virus 
dilutions. 
By changing the concentration of the phosphate buffers 
in the diluent used for the erythrocytes (PBS), the final pH 
of the test could be varied between 5.5 and 6.3, and the effect 
.of pH on HA titers observed. The titers of the Records var­
iants changed only by one or two dilutions throughout this 
pH range,'but the highest titers were observed at pH 6.0 
for each variant. 
Table 7 contains typical HA test results, with the ti­
tration endpoints shown for each variant. When calculated, 
the PPU/HA ratios ranged from 4.4- x 10^ to 7.5 x 10^, with 
no consistent differences between the variants detected. 
Hemagglut inat ion-inhibit ion t est s ' • 
HI tests were performed with both the l4-day.ahd 35-
day guinea pig antisera with results as shown in Tables 8, 
9 and 10 for the three Records variants. 
Table 7. Hemagglutination'test results 
Tube number: 12 3 4 5 6 7 8 9 10 11 12 
Dilution:* 10 20 40 80 I60 320 640 1280 2560 5120 10240 20480 
Antigen; 
b c 
LP + + + + + + — — — — — — 
MP + + + + + + + + + — — — 
S P  +  • +  +  +  +  +  —  —  —  —  —  —  
I 
Control — — ^ — — — — 
^Reciprocal of antigen dilution in BBS, pH 9.0, prior to addition of cells. 
^(+) = Complete hemagglutination. 
^(-) = No hemagglutination. 
Table 8. Results of HI test using LP antigen 
Tube number: 1 2 3 4 5 6 7 8 9 10 11 12 
Dilution:* 20 40 80 160 320 640 1280 2560 5120 10240 20480 40960 
Antiserum: 
LP 14 _b - - - - - - +  +  +  " + "  
MP 14 - - - - - - +  +  +  +  +  +  
SP 14 - - - - - +  +  +  +  +  +  
Control 14 +  +  +  +  +  +  +  +  • +  +  +  +  .  
LP 35 - - - - - - - +  +  +  +  +  
MP 35 - - - - - - +  + +  +  + 
SP 35 - - - - - - + .  + +  +  .  +  +  
Control 35 +  +  + '  +  +  +  +  +  +  +  +  +  
^•Reciprocal of serum dilution in BBS, before addition of virus and cells. 
^(-) = Hemagglutination inhibited. 
®{+) = Complete hemagglutination. 
Table 9. Results of HI test using MP antigen 
Tube number: 1 2 3 4 5 6 7 8 9 10 11 12 
Dilution:* 20 40 80 160 320 640 1280 2560 5120 10240 20480 40960 
Antiserum; 
LP 14 _b - - - - - - - - + + 
MP 14 - - - - - - - - - + + + 
SP 14 - - -
-
- - + + + + + • + 
Control 14 + + + + + + + + + + + + 
LP 35 • - - - - - — •  - - + + + + 
MP 35 - - - - - - - - + + + + 
SP 35 - - - - - + + + + + + 
Control 35 + + + + + + + + + + + + 
^Reciprocal of serum dilution in BBS, "before addition of virus and cells . 
^(-) = Hemagglutination inhibited. 
®(+) = Complete hemagglutination. 
Table 10. Results of HI test using SP antigen 
Tube number; 1 2 3 4 5 6 7 8 9 10 11 12 
Dilution:® 20 40 80 160 320 640 1280 2560 5120 10240 20480 40960 
Antiserum: 
LP 14 _b - - - - - - + +• + + 
MP 14 - - - - - - + + + + + + 
SP 14 - - - - - - - - + + + + 
Control 14 + + + + + + + + + + + + 
LP 35 - - - - - - + + + + + + 
MP 35 - - - - - + + + + + + 
SP 35 - - - - - - + + + + + + 
Control 35 + + + + + t + + + + + + 
^Reciprocal of serum dilution in BBS, before addition of virus and cells, 
^(-) = Hemagglutination inhibited. 
°(+) = Complete hemagglutination. 
% 
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'Prom^a general comparison of HI titers of the 
antisera, it Aay be seen that the 35-day sera-were in 
some cases even lower titered than the earlier l4-day 
samples. Also, as might be expected, there was some 
loss of specificity in the antisera collected later in 
the course of immunization. 
In general, the HI test results provided a less 
sensitive comparison of the antigenic differences 
between the Records variants than did the cross-
neutralization test. Only in the case of the MP and 
SP variants was a significant difference observed. 
Anti-MP serum inhibited hemagglutination by the homologous 
antigen at an antiserum dilution of 1:5120, but inhibited 
the SP variant only as high as a 1:640 dilution. A four­
fold difference in the titers was seen in the 35-day 
antiserum. In the reverse situation, the early SP anti­
serum did possess a four-fold difference in HI titer 
between test results with the homologous and MP hemag­
glutinins. This difference in titer was not apparent 
however, in the 35-day sample. 
Significant differences between the LP and MP 
antigens or between the LP and SP antigens were not 
apparent in the HI test results. 
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DISCUSSION AND CONCLUSIONS 
Plaque Diameter Comparisons 
Recent WEE isolates 
Western equine encephalomyelitis virus populations, 
as they are isolated from naturally infected hosts, 
produce predominantly large plaques. This conclusion 
is based on the results of this study, in which seven WEE 
isolates from three different hosts and from three dif­
ferent states were all found to have mean plaque diameters 
very closely resembling that of the LP Records variant. 
A similar conclusion was reached by Marshall ^  al. (3^) 
after their study of the plaque-size properties of six 
WEE isolates obtained in California, in 1958. 
However, it may also be concluded, as did Ushijima 
et al. (57)f that a degree of plaque-size heterogeneity 
exists in field strains of WEE virus. In the present 
study, medium-type plaques were observed during the 
standard plaque titrations of nearly all of the isolates. 
A possible reason for the failure to observe small plaques 
during the field strain titrations will be a topic for 
later discussion. 
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The Records strain 
It has been shown that, after years of serial chicken 
embryo passage, the Records strain produced plaques 
which were apparently all In the medium size range. 
Judging by the plaque characteristics of the Records 
strain, it might be concluded that serial chicken embryo 
passage had selected for the MP variant from among a 
population which on Initial Isolation (like most field 
strains) could conceivably have been predominantly LP 
In character. 
However, Marshall et al. (34) have suggested serial 
passage in chicken embryos as the only means of preserving 
the LP characteristic of wild strains of WEE virus. How­
ever, they did report the observance of medium-size plaques 
after chicken embryo passage of several strains of WEE 
virus. Thus their statement actually means that the mean 
plaque diameters of wild strains-were not observed to 
decrease as rapidly during chicken embryo passage as they 
did in several other hosts. 
Brown and Packer (4) reported that small plaques 
(2.0 to 5.0 mm. in diameter) became the predominant plaque 
type after 5 serial chicken embryo passages of a partially 
purified LP population. But, as Indicated by the Inclusion 
of the actual numerical values for the range in plaque 
diameter, medium-type plaques had actually been observed. 
109 
It was only after additional cloning experiments that 
a true SP variant (with typical plaques 0.5 to 2.5 mm. 
in diameter) was recognized within the Records strain. 
Derivation of the Records variants 
"It is not known with certainty whether the LP and 
SP Records variants resulted from mutations of a relatively 
unstable MP variant, or whether they only appeared in the 
Records strain as a result of host selection from among 
a heterogenous population. The evidence which has thus 
far been accumulated, does however, strongly favor the 
hypothesis that the Records strain originally existed as 
a heterogenous population of at least the large and the 
medium plaque-size variants. Unless a minor component 
of a virus populations produces plaques which approximate 
nearly 1 percent of the total number, their presence is 
difficult to detect by plaque titrations. The medium 
plaque-type majority could therefore have masked the 
presence of the LP type until, as a result of host selection 
during guinea pig kidney cell culture passages, the relative 
proportion of the LP variant was increased. 
Many research groups (5, 22, 30 and 45) have reported 
the observation of host-selection phenomena during the 
serial passage of WEE virus populations. It is probably 
then, not just coincidental that the LP and SP variants 
were first detected after serial passages of the predominantly 
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MP Records population in different host species. Circum-
' s 
stantial evidence indicates that serial passage in guinea 
pi^ kidney cell cultures may have been responsible for the 
appearance of the LP variant in one sample of the Records 
strain. There is also evidence that serial passage of 
another sample of the same virus in the brains of weanling 
mice was associated with the initial detection of the 
SP variant. 
Host-selection phenomena are possible, of course, 
only when a mixed population is used for serial passage. 
When either the LP or MP variant exists as a plaque-
purified population, they can be serially passed in CE 
cell cultures without detectable change in their mean 
plaque diameters. Both variants thus appear to be rather 
stable genetically. The changes in the plaque-size 
characteristics.of SP populations which have been observed 
during serial passage can be attributed to their existence 
in an impure state. The significantly higher rate of 
accumulation of the MP variant following mixed SP-MP cell 
culture infection is likely a major factor governing the 
rapidity with which the MP variant becomes the major 
component of cell-culture-propagated populations. However, 
the questionable genetic stability of the SP variant might 
well be another factor contributing to the rapidity of 
this change. 
Ill 
since replication of the MP variant is selectively 
favored in CE cell cultures, it is not at all surprising 
that the attempts to selectively clone the SP variant 
from amidst a mixed SP-MP population have met with 
considerable difficulty. One might suspect that serial 
intracranial passage in mice, if carried out at limiting 
dilution, might prove to be a more efficient method of 
purifying a predominantly SP population. At least in 
this host, replication of the SP variant would be selectively 
favored. Prom this viewpoint, it is interesting to consider 
the plaque properties of the Olitsky strain of WEE virus, 
as reported by Marshall et al. (34). The Olitsky strain 
has undergone Innumerable serial mouse brain passages, and 
not surprisingly produces predominantly small plaques. But 
Marshall's group detected larger plaques (probably the 
MP variant) which comprised about 2 percent of the total 
number counted from Olitsky strain titrations. These results 
suggest that even serial mouse-brain passage would not 
result in a pure SP variant population. One might be led 
to speculate as to why the results of this study and that 
of Marshall and his coworkers might agree so closely with 
respect to the actual percentage of larger plaques detected 
in a SP population on its initial titration in CE cells. 
The figure of approximately 2 percent impurity has been 
Independently determined as a result of both studies. 
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Could this figi^e of '2 percent be associated with a 
rather constant but relatively rapid back-mutation rate 
of the SP variant? 
Field strains of WEE virus apparently do not produce 
small plaques when titrated by the standard plaque assay 
procedure. This fact, along with others, might suggest 
that the SP variant is strictly a laboratory curiosity 
which represents the neuro-adapted form of WEE virus. 
It lends added significance to the initial observation 
of the SP variant in samples of the Records strain only 
after serial mouse-brain passage. The SP variant probably 
differs genetically from the other variants, but represents 
a relatively unstable form. Host selection during intra­
cranial passage in mice may be responsible for the per­
petuation of this genotype in the laboratory, although 
even in this host, a rapid back-mutation rate might never 
allow it to exist in pure form. Its relatively rapid 
back-mutation rate, coupled with preferential host selection 
for the other variants and its relatively low peripheral 
virulence may all be contributing factors which might 
explain why the SP variant is seldom if ever isolated from 
naturally infected hosts. 
Characteristic plaque size of the Records variants 
The most confusing aspect of the literature dealing 
with WEE virus plaque-size variants is the variety of 
/ 
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environmental conditions used by the different research 
groups for plaque comparisons. These differences make 
correlation of the results reported by the different groups 
especially difficult, and may be primarily responsible for 
the apparent discrepancies found in the literature. For 
this reason, it will again be stressed that all plaque 
comparisons reported in this study were made under environ­
mental conditions that were strictly controlled. 
The values shown in Figure 2 of the preceding section 
may be taken as the most typical plaque diameter range and 
mean for each Records variant as obtained by the standard 
plaque assay procedure. It should also be re-emphasized 
that the classification of the Records strain of WEE virus 
into three plaque-size variants was not arbitrarily done. 
It can be shown statistically that 99 times out of 100, 
the plaques found in each classification could only have 
been produced by virus particles with significantly different 
properties. Therefore, the plaque diameter variation being 
studied was directly attributable to differences in the 
Records variants, and not due to environmental conditions. 
Effects of agarose overlays 
Even though the large and medium type plaques 
resembled each other more closely under agarose overlays 
than they did by the standard plaque assay procedure, a 
significant difference in their mean plaque diameters 
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could still be statistically demonstrated. With agarose 
overlays, the plaques produced by the MP variant were 
significantly larger than those of the LP variant, results 
which were in direct contrast to those obtained under Noble 
agar. But, these differing results are explainable. 
It has been shovm that the HP variant, of the two 
being discussed, is more susceptible to the inhibitory 
effects of sulfated polysaccharide. V/ith a comparatively 
lower level of polysaccharide sulfate inhibitor in agarose, 
the full growth potential of medium-type plaques is then 
more likely expressed. In CE cell cultures maintained 
with a fluid medium (in the absence of agar) the MP variant 
has a demonstrably higher rate of accumulation. Since the 
rate at which MP virus particles are made available for the 
infection of adjacent cells is slightly greater than for 
the LP variant, the plaques produced by the MP variant 
evidently achieve a slightly greater diameter in the 
specified 48-hour time interval allowed for development. 
In a similar way, one can explain the results observed 
with the SP variant. Under Noble agar overlays, development 
of small plaques is limited by the low growth potential 
of the SP variant in CE cells, and even further limited 
by the susceptibility of the SP variant to polysaccharide 
sulfate inhibition. When the inhibitor is present in lesser 
concentration, as in agarose overlays, the low rate 
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of accumulation of the SP variant in the,cultures still 
remains as the principal factor limiting plaque develop­
ment. Although they are perhaps equally inhibited by the 
sulfated polysaccharide, the SP and MP variants still differ 
markedly in their respective rates of accumulation. Thus, 
the difference between small and medium plaques is even 
greater under agarose than when these two variants are 
titrated by the standard plaque assay procedure. 
It might therefore be concluded that the character­
istic plaque size of each variant under agarose overlays 
is in direct proportion to the rate of accumulation of . 
newly synthesized virus in the cell cultures. If this 
conclusion is correct, it serves as excellent corroboration 
of the results obtained in the growth rate studies. It 
also agrees with the observation that the MP variant is 
most likely to be selected from a mixed population of 
WEE virus during serial passage in CE cell cultures or 
in embryonated eggs. 
Effects of inhibitors added to agarose overlays 
Colon and his collaborators (9. 10 and 11) reported 
the effects of sulfated polysaccharide from agar after 
studying only a susceptible or SP variant of WEE virus. 
Other groups have demonstrated the effects of the inhibitor 
only by indirect means. For example, DEAE dextran used in 
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Noble agar overlays by Ushijima et al. (57) was apparently 
responsible for significantly increasing the diai^eter of 
" * - f 
their SP, variant by blocking the action of the agar 
inhibitor. Since the relative degree of increase of the 
small plaque type was greater than that of the large, these 
workers were able to suggest that a difference in inhibitor 
susceptibility existed between the two variants. 
In the current study, the use of agarose overlays 
provided an opportunity to directly determine the effects 
of various inhibitory polysaccharides on the plaque diameter 
of each Records variant. The results indicate that all 
three variants are susceptible to the inhibitory effects 
of sulfated polysaccharide preparations, and that inhibitors 
in the overlay actually do cause a marked decrease in the 
size of the plaques which each produces. Of the three 
variants, the LP was the least affected by the addition 
of crude inhibitor preparations from Noble or Bacto agars. 
This lower susceptibility of the LP variant is the principal 
factor responsible for its production of large plaques 
under Noble agar overlays. Yet, in the concentration 
used, dextran sulfate caused a reduction in the size of 
the large plaques to the point where they became indis­
tinguishable from those produced by the MP variant under 
the same conditions. This indicates that the LP variant 
is not totally resistant to the effects of sulfated 
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polysaccharide, anâ that the difference between it and the 
- . ) 
MP variant in this respect is only relative. 
Effects of cysteine and lactalbumin hydrolysate added 
to skim milk overlays 
Under skim milk-Noble agar overlays, all three 
Records variants produced smaller-than-normal plaques. 
Addition of cysteine to the overlay medium caused an 
increase in the mean plaque diameter of each variant, 
but only after the addition of lactalbumin hydrolysate 
(LAH) did the resulting mean plaque diameters approximate 
those normally obtained by the standard plaque assay 
procedure. It has been demonstrated that this plaque-size 
increase was not the result of a correction of a nutritional 
deficiency of the skim milk overlay medium. Instead, it 
apparently resulted from a decrease in the susceptibility 
of the variants to inhibition by the sulfated polysaccharide 
of Noble agar. Under skim milk-agarose overlays, larger 
plaques developed even without the addition of cysteine 
or LAH. 
It may be concluded that the characteristic plaque 
diameters of the three Records variants under the standard 
plaque assay conditions are dependent on the presence of 
the sulfated polysaccharide of Noble agar and possibly on 
the cysteine of the LAH which are both customarily used 
in the overlay medium. 
P 
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It is also readily apparent that the resistance 
to polysaccharide sulfate inhibition of the LP variant, 
in comparison to the other two, is more significantly 
enhanced by the presence of LAH in the overlay. The 
principal difference between the LP and MP Records 
variants is marked by this difference in their resistance 
to plaque inhibition by sulfated polysaccharide. In 
the absence of cysteine of LAH, even this distinction is 
no longer demonstrable. 
According to Wallis and Melnick (58), a 0.5 percent 
solution of LAH would be 0.5 millimolar with respect to 
cysteine. In their studies with the enteroviruses, they 
apparently assumed that the protective effect of LAH 
was principally due to its cysteine content. The three 
Records variants produced larger plaques in the presence 
of 0.5 percent LAH than in the presence of the 2.0 
millimolar concentration of cysteine (4 times the equivalent 
initial cysteine concentration). Due to the characteristic 
instability of cysteine in aqueous solution, it is difficult 
to determine whether or not some other component of LAH 
may also have had a protective effect for the Records 
variants in the current study. 
Effects of bovine serum 
It has been demonstrated, that under either Noble agar 
or agarose overlays, bovine serum in 5 percent concentration 
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slightly inhibits the development of medium-size, plaques. 
This result is in close agreement with other effects of 
bovine serum observed during the current study. It is 
known that traces of bovine serum, if present in HA antigens, 
will markedly inhibit hemagglutination of chick erythrocytes 
by the Records variants. During propagation of the MP 
variant in CE cell cultures, higher virus titers were 
obtained, and cytopathic effects were observed to occur 
more rapidly if bovine serum was omitted from the fluid 
maintenance medium. Thus, as is shown by its inhibitory 
effect on MP development, bovine serum probably contains 
some component which is capable of direct interaction 
with the MP variant and therefore reduced the effective 
concentration of free virus particles during CE cell 
culture infection. 
The inhibitory effects of serum are more readily 
apparent with the MP variant than with the other two. 
As indicated by the decrease in its mean plaque diameter 
caused by the addition of bovine serum to agarose overlay 
medium, the LP variant is also susceptible to the inhib­
itory effects of -serum. V/hy then, was an opposite effect 
observed under Noble agar overlays when bovine serum was 
added? It is possible that the presence of serum might 
enhance the resistance of the LP variant to the inhibitory 
effect of sulfated polysaccharide, in the same manner as 
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has already been demonstrated for cysteine and lactalbumin 
hydrolysate. This enhancing'effect may likely be greater 
than the inhibitory activity of serum, and a net reduction 
in mean plaque diameter was therefore detectable only under 
agarose overlays where the enhanced resistance to sulfated 
polysaccharide was of no consequence in plaque-size deter­
mination. This enhancement was not seen in the case of 
the MP variant under Noble agar since perhaps serum (like 
LAH) only partially protects the MP variant against inhibition. 
Since the rate of accumulation of the SP variant 
in CE cell cultures is already limited, any inhibitory 
effects of serum on its plaque development might possibly 
remain undetected. However, if any significant effect of 
serum was observed, it was a slight enhancement, both under 
Noble agar and agarose overlay media. It is possible that 
the SP variant is less likely to react with bovine serum 
than are the other two variants. During other experiments 
there was additional evidence in support of this conclusion. 
On several occasions, it was observed that the SP character 
of a relatively pure SP population was more readily main­
tained during passage in CE cell cultures if 5 percent 
bovine serum was added to the fluid maintenance medium. 
In the absence of serum, the resulting populations often 
contained a higher proportion of the MP variant. This 
observation suggests that of the two, the MP variant is 
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more strongly inhibited by bovine serum. Its relative 
non-reactivity with bovine serum may be still another 
distinctive property of the SP Records variant. 
Virus and sulfated polysaccharide interaction 
A number of research groups have studied the reactions 
of viruses with the inhibitory sulfated polysaccharides. 
Most studies have resulted in conclusions similar to those 
of Colon ^  a2. (9, 10 and 11) who have investigated the 
effects of agar extracts and dextran sulfate on several 
arboviruses. Although an inhibitor-host cell interaction 
could not be completely disproven, Colon and his coworkers 
concluded that a direct interaction between sulfated poly­
saccharide and the virus particle was the most likely cause 
of inhibition of WEE virus plaque development. 
Mahmias et (i|-3) investigated the effects of a 
group of synthetic and biological polyanions on herpes 
simplex virus plaque formation. In order to possess 
inhibitory activity, the compounds they studied needed to 
be of a minimum molecular size or degree of polymerization. 
The activity of these inhibitors was clearly a function 
of their sulfate ion content and not solely due to negative 
charge, since hyaluronic acid (which contains negatively 
charged carboxyl groups) was found to be inactive. The 
polysaccharide structure itself was unnecessary, as evidenced 
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for example, by the inhibitory effect of polyvinyl alcohol 
and polystyrene sulfonate. 
Similar conclusions can readily be made from the 
results of this study with the Records variants." The 
decreased sulfate ion content of agarose in comparison 
to Noble agar is probably responsible for the significantly 
decreased inhibitory activity of agarose overlays. Further­
more, inhibition of WEE virus plaque development was directly 
attributable to the addition of sulfated polysaccharide, 
either in the form of agar extracts or as dextran sulfate, 
to agarose overlays. 
The principal difference between the LP and MP Records 
variants is associated with their apparent difference in 
susceptibility to plaque-inhibition by sulfated agar poly­
saccharide. It might initially be assumed that some specific 
property of the LP variant might account for its relative 
nonreactivity with the sulfate ion of agar polysaccharide. 
Other research workers have actively searched for 
differences in the physical and chemical properties of 
inhibitor-susceptible and inhibitor-insusceptible variants. 
Working with VEE virus, Heydrick et al. (23) detected 
differences in banding patterns between LP and SP variants 
in sucrose density gradients, and also a difference in the 
' ratios of soluble to Insoluble lipids. From a study of 
the amino acid composition of proteins obtained from three 
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plaque-size variants of encephalomyocarditis virus, Moscarello ^ 
and Kaighn (40) detected several minor differences. However, 
the detectable differences reported by either group were 
probably not sufficient to account for a significant 
difference in the reactivity of these variants with the 
sulfate ion of polysaccharide inhibitors. 
According to Moscarello and Kaighn, the remarkably 
low concentration of sulfur-containing amino acids in 
encephalomyocarditis virus proteins was perhaps the most 
interesting feature of their results. They commented that 
low levels of methionine, cystine and cysteine seem to be 
a universal property of all animal virus proteins which 
have thus far been analyzed. 
Possible significance of the protective effect of cysteine 
It has been demonstrated that there is only a relative 
difference between the LP and MP Records variants in their 
susceptibility to the Inhibitory effects of sulfated poly­
saccharide. There was evidence that the relatively greater 
resistance of the LP variant was overwhelmed by the addition 
of dextran sulfate to agarose overlays. Under skim milk 
overlays, devoid of lactalbumin hydrolysate (LAH), there 
was virtually no difference in the susceptibility of these ' 
two variants to sulfated polysaccharide Inhibition. It might 
therefore be concluded that the LP and MP variants are both 
capable of direct reaction with sulfate ion and that the LP 
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variant, of the two, is preferentially protected from entering 
into this reaction in the presence of LAH. Since cysteine 
shows a similar sparing effect, there is also reason to 
• believe that this protective activity of LAH is at least 
in part related to its cysteine content. These latest 
findings may perhaps explain why the detectable differences 
in the physical and chemical properties of plaque-size 
variants might not satisfactorily account for a difference 
in their tendencies to react directly with sulfated 
polysaccharide. 
A possible mode of action of cysteine and LAH 
Protamine sulfate {^•) or DEAE dextran (57), if added 
to Noble agar overlays, have also been reported to cause 
a demonstrable increase in the plaque size of WEE virus, 
A logical assumption might be that these polycations play 
a protective role by reacting with the negatively charged 
sulfate groups of the inhibitor, thereby preventing their 
reaction with the susceptible virus. The nondiscriminatory 
protective effects of DEAE dextran or protamine sulfate 
may thus be explained. A direct reaction between cysteine 
and the sulfated polysaccharide could also be postulated, 
however its occurrence would not readily explain the 
preferential protection of the LP variant as contrasted to 
the other two. Therefore, it might be suggested that 
cysteine instead exerts its protective influence by reaction 
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With the virus itself. If this is the case, it could also 
• be assumed that the preferential protection of the LP variant 
is a result of a difference in its reactivity with cysteine 
or perhaps with a similar component of LAH. 
This hypothesis is strongly supported by the observations 
of Wallis and Melnick (5B) who have studied the protective 
effects of cysteine for the Pesascek echovirus. Not only 
is this LP echovirus variant protected against plaque 
inhibition by sulfated polysaccharide, it is also stabilized 
against heat-inactivation in the presence of cysteine. 
Clearly this latter effect must be due to the influence of 
cysteine on the virus itself, since heat-inactivation studies 
were carried out in the absence of sulfated polysaccharide. 
Surely, additional studies of the reactions of cysteine 
and similar compounds with the Records variants might result 
in valuable information concerning the surface properties of 
these and similar infective agents. 
Virulence Comparisons 
Comparison of host sensitivity 
The principal purpose of the virulence trials was 
to investigate possible differences in virulence which 
might exist among the three Records variants. This pur­
pose was accomplished by parallel titrations of similar 
preparations of each variant in several different laboratory 
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hosts. However, before any general conclusions may be drawn, 
it is necessary to first consider the relative susceptibility 
of the various host species to WEE virus infection. This 
rating of the hosts according to their apparent sensitivity 
is more meaningful if the results of the SP variant titrations 
are initially disregarded. It was observed in this study, 
that the highest titration endpoints with both the LP and MP 
variants were reached after infection of |--day-old chicks. 
In the order of decreasing sensitivity, one could further 
list the standard plaque assay procedure in CE cell cultures, 
intracranial injection of weanling mice, intra-allantoic 
infection of chicken embryos and finally, titrations in 
weanling mice by the intraperitoneal route. This rating 
of host sensitivity is coincidentally the same as the order 
in which they might be selected for use in the isolation 
of WEE virus from field specimens, since wild strains are 
also MP and LP in character. 
Relative virulence of the Records variants 
The results of the virulence trials demonstrate that 
there is little difference in the virulence of the LP 
and MP variants. In each of the laboratory hosts tested, 
nearly identical infective titers were obtained for these 
variants. 
Significantly different results were obtained however, 
with the SP variant. Only in mice injected intracranlally. 
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did the SP variant demonstrate virulence closely comparable 
to that of the other two. Despite the presence of the MP 
Variant impurity, the SP variant preparation did not produce 
deaths of mice Inoculated intraperitoneally or deaths of 
embryos after intra-allantoic injection of embryonated eggs. 
The deaths which did occur in the baby chicks after sub­
cutaneous administration of the SP inoculum are thought 
to be due, at least in part, to the MP impurity which it 
contained. Since the MP variant was present in sufficient 
concentration to be detectable by cell culture titrations, it 
is not surprising that its presence was also detected by 
infection of baby chicks, an even more sensitive titration 
procedure. Thus, for the first time, it has been observed 
that there is a direct relationship between virulence and 
plaque-size characteristics of V/ES virus. 
The SP marker and virulence 
The results of the virulence trials are closely com­
parable to those reported by Hearn ^  a2. (20) and Hardy 
and Hearn (19) after their investigations with VEE virus. 
Also, Chamberlain et al. (5) have reported that the mouse-
adapted Plemming strain of WEE virus (presumably also a 
SP strain) possessed decreased virulence for baby chicks, 
and Kissling (30) has noted that a loss of peripheral 
virulence results from serial Intracranial passage of 
most arboviruses. Therefore, the observation of the 
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reduced peripheral virulence of the SP variant in this 
study was not unexpected, and was essentially a confirm­
atory finding. One main conclusion, supported by previous 
observations, may be drawn as a result of the virulence 
trials with the Records variants. It may be stated that 
the SP marker which appears during serial intracranial 
passage of a WEE virus population is visible indication 
that this population then possesses reduced virulence for 
many potential hosts. 
AutoinhibitIon effects 
The results of virulence trials in embryonated eggs 
indicated that embryos were partially protected against 
the lethal effects of MP infection in the presence of the 
less virulent SP variant. Additional evidence which suggests 
that the SP variant is capable of interfering with the 
replication of the MP variant was obtained by growth rate 
comparisons in CE cell cultures. The MP variant was observed 
to accumulate at a rapid rate in cultures after infection 
with a pure MP inoculum. But, its rate of accumulation was 
comparatively slower after a mixed MP-SP infection. While 
neither of the experiments was specifically designed to 
detect interference by the SP variant, the results strongly 
suggest that it did occur. 
Dunayevitch et al, (18) observed similar interference 
effects caused by a variant of low pathogenicity found to 
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be a component of a field strain of WEE virus. The results 
of the current study with the Records variants lend support 
to their conclusion that the presence of a non-pathogenic 
variant in a mixed population of WEE virus may protect 
animals against the lethal effects of infection by the 
more virulent variant. 
Stability of the SP variant 
It has been shown that the relatively avirulent SP 
variant has been impossible to purify by selective cloning 
procedures. After only two serial passages in CE cell 
cultures with fluid maintenance medium, the MP variant 
again represents the majority of the virus population. 
From the results of titrations in embryonated eggs and in 
baby chicks, there is also evidence that, along with its 
change in plaque characteristics, this population also 
regains much of its original virulence. Failure to 
regain complete virulence might be accounted for by. 
the interference effects just described, as long as the 
SP variant was also present in the population. It might 
therefore be concluded that this apparent instability of 
the SP Records variant is a highly undesirable property 
which would eliminate it from consideration as a possible 
live-virus vaccine strain. 
The clone 15 variant currently being investigated 
as a potential live-virus vaccine was derived from the 
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mixed WEE virus population studied by Dunayevitch et al. 
(18). Although its plaque-size properties were not con­
sidered during the selective cloning of this variant 
from the original heterogenous population, Johnson^ has 
stated that the clone 15 variant, in its current form, 
still produces a mixture of small and intermediate-sized 
plaques in chicken embryo cell cultures. Although the 
clone 15 variant resembles the SP Records variant in many 
of its properties, one must hope that it at least proves 
to be much more stable than the Records variant during 
serial passage experiments. 
Comparison of Antigenic Properties 
The SP marker 
The results of serum neutralization tests and of 
hemagglutinatlon-inhibition tests both indicate that 
the SP variant possesses antigenic properties signif­
icantly different from those of the other two Records 
variants. The degree of difference among the three 
variants is also suggested when the quantitative differ­
ences in antiserum titers are considered. It might appear, 
as a result, that the SP variant is more closely related 
^•Johnson, H. N. The Rockefeller Foundation, Berkeley, 
California. Unpublished observations. Private communication. 
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In its antigenic structure to the LP variant, and more 
distantly related to the MP variant. And, of the three, 
the closest relationship is between the LP and MP variants. 
Henderson'and his collaborators (21, 22, 28 and 52) 
have demonstrated the antigenic heterogeneity of WES virus 
populations, host selection of antigenic variants accompany­
ing serial passage and differences in.the replication rates 
of respective variants in CE cell cultures. A marked 
difference in the antigenic properties of newly isolated 
strains and mouse-passaged laboratory strains has also 
been detected, first by Olitsky et (45) and later by 
Karabatsos et . (28). It may be surmised that the Olitsky 
strain, as later reported by Marshall and his coworkers (3^), 
existed principally as the SP variant. These previously 
reported findings are all quite similar to the results 
of the current study. The close correlation of the 
results obtained by all these research groups clearly 
demonstrates that the SP marker may well be a significant 
indicator of change in the antigenic properties of WEE 
virus. Therefore, the observation of small plaques resulting 
from the titration of a population of WEE virus in CE cell 
cultures is an indication that this population has under­
gone significant changes, both in virulence and in antigenic 
properties, from its characteristic wild state. 
The antigenic change which WEE virus populations are 
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observed to undergo during serial intracranial mouse passage 
has, in the past, confused the virologist who was attempting 
to identify newly isolated field strains. For example, 
the antigenic differences between a LP field strain and a 
SP laboratory strain might be nearly as great as the anti­
genic differences between the field strain and another 
arbovirus. The results of serological tests might be 
more easily interpreted if the antigenic properties of new 
isolates were compared with those of the plaque-purified LP 
variant, and not with those of mouse-propagated stock 
strains which are more likely to be predominantly SP in 
character. 
Since hemagglutination-inhibition tests are most 
likely to be used for the initial Identification of many 
new arbovirus isolates, a case might be made for the 
propagation of HA antigens in CE cell cultures rather 
than their propagation by intracranial passage in suckling 
mice. Satisfactory HA antigens can be produced in cell 
cultures by a method which does not require complex pre­
paratory procedures. And since the use of a plaque-purified 
LP antigen is advisable, its purity could be more readily 
maintained and monitored by cell culture propagation 
procedures. 
A discussion of the antigenic differences of the SP 
variant would not be complete unless there was an explanation 
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of why other investigators of WEE virus plaque-size 
variants failed to detect this apparent difference. In 
most of the other studies, reciprocal cross-neutralization 
1 
tests were not employed. None of the other groups used 
guinea pig antisera. And, because of the apparent 
instability of the SP variant, the use of formalin-
inactivated antigens in the current study was probably 
the principal reason for its success. 
The LP and MP variants 
The antigenic differences between the LP and MP 
variants appear to be less distinctly demonstrable. 
Additional and more definitive studies may be necessary 
before the full significance of these apparent differences 
can be assessed. Antibody absorption studies with each of 
the variants, patterned after those of Clarke (6, 7) with 
the group B arboviruses, would seem to be a logical approach 
to further investigation. 
134 
SUMMARY 
Three plaque-size variants were selectively cloned 
from the Records strain of WEE virus after its serial 
passage in several different host species. They were 
designated as the LP (4 to 7 mm.), MP (2 to 5 mm.) and 
SP (0.5 to 2.5 mm.) Records variants. These characteristic 
ranges in plaque size were dependent on the presence of the 
sulfated polysaccharide of Noble agar and the presence of 
lactalbumin hydrolysate (LAH) in the overlay medium during 
a standardized plaque assay procedure in CE cell cultures. 
The LP and MP Records variants have many properties 
in common. Each could be obtained in pure population by 
the selective cloning procedure. They both appear to be 
rather stable genetically and are of nearly equal virulence 
for many laboratory hosts. Normal bovine serum slightly 
inhibits infectivity and hemagglutinating activity of both. 
They differ only slightly in antigenic properties and there 
is perhaps a small difference in their growth rates during 
CE cell culture infection. Under agarose overlays which 
are known to be low in sulfated polysaccharide, their 
mean plaque diameters are quite similar. 
The principal difference between the LP and MP Records 
variants is in their relative susceptibility to plaque 
inhibition by sulfated polysaccharide. The significantly 
greater resistance of the LP variant to reaction with 
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sulfated polysaccharide is primarily responsible for its 
production of large-type plaques under standard assay 
conditions. This resistance of the LP variant is attributable, 
at least in part, to the cysteine component of LAH.which 
exerts a preferential protective effect on the LP variant. 
The possible significance of this finding is discussed. 
Newly isolated field strains of WEE virus typically 
produce both large and medium type plaques. Small plaques 
were not detected during the titrations of seven new isolates, 
and were found in the. Records strain only after its serial 
intracranial passage in weanling mice. 
The SP Records variant, in comparison with the other 
two, possesses many distinguishing properties. It was 
not possible to prepare a pure SP variant population by 
selective cloning in CE cell cultures, a possible indication 
of genetic instability of this variant. In mixed infection, 
the SP variant apparently interfered with the replication 
of the MP variant. Of the three variants, the SP is 
perhaps the least reactive with normal bovine serum. 
The SP variant accumulated in the maintenance medium 
of infected CE cell cultures at a rate significantly lower 
than the other two. This fact may account for its production 
of plaques significantly smaller than those of the other 
two variants under agarose overlays. An additional 
factor responsible for its production of even smaller 
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plaques under the standard plaque assay conditions is 
its suceptibility to inhibition by agar polysaccharide. 
Of perhaps greater importance are the observations 
that the SP variant possesses markedly reduced peripheral 
virulence for several hosts, and is antigenically distin­
guishable from the other variants. These findings are 
compared and correlated with those of other investigators, 
and the significance of the WEE virus SP marker is 
discussed. 
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, APPENDIX 
Table 11. Diameter of plaques produced by the Records strain and by the 
three Records variants under standard plaque assay conditions 
Virus ; Î 2 3 5 5 
Plaque diameter (mm.) 
"T 7 3 9 ÏÏÏ Mean a 
Records 
strain 
1° 24 50 12 3.9 
LP variant 2 53 76 13 1 5.5 
-fr 
MP variant 2 22 29 2 3.7 
SP variant 189 92 5 1.3 
^Mean plaque diameter (mm.). 
^None observed. 
^Number of plaques. 
Table 12. Comparison of the plaque diameters of seven recent isolates 
with those of the Records variants 
Plaque diameter (mm.) 
Virus ; 1 2 3 4 6 7 8 9 10 Mean 
LP variant _b -
- — 
20° 35 12 1 — — 5.9 
MP variant 
- 13 75 22 1 - - - — — 3.1 
SP variant 150 21 - - - - - - — — 1.1 
65V-241 - - - - 20 35 12 1 — — 5.9 
65v-796 - 2 - - 6 8 3 1 — — 5.6 
65v-657 - - - - 11 28 6 - — — 5.8 
65V-692 - 3 - 2 28 12 2 - — — 5.1 
65V-633 - 2 - 5 20 16 - - — — 5.1 
65V-629 - 1 4 5 22 37 1 - — — 5.3 
E 2329 - 2 1 18 36 33 14 - — — 5.3 
&Mean plaque diameter (mm.). 
^None observed. 
^Number of plaques. 
Table 13. Plaque diameters of the Records variants under Noble agar 
or agarose overlays 
Plaque diameter (mm.) 
Overlay: 1 2 3 4 5 6 7 8 9 10 11 
a 
Mean 
LP variant ' rf : • >" 
Noble agar _b - - 2® 53 76 13 1 - - - 5.7 
Agarose - - - - 6 37 3 - -
) 
7.5 
MP variant 
Noble agar 2 22 292 2 . 3.5 
Agarose - - - - - 3 4 13 17 15 3 8.9 
SP variant - • 
Noble agar 189 92 5 - - - - - - - - • ' 1.3 
Agarose - - 31 131 61 6 - 1 - - - 4.2 
^Mean plaque diameter (mm.). 
^None observed. 
^Number of plaques. 
M 
Table 14. Effect on plaque diameters of inhibitory substances added to agarose 
overlays 
Substance 
Plaque -diameter (mm.) 
added: 0.5 1 2 3 —4- 6 • 6 7 . •"8 9 10 Mean 
LP variant 
AE _o — — 7^ Id 8 17 1 6.9 
NE — — — — 1 10 12 9 " — 6.9 
BE — — — 1 12 23 8 1 — — 4.9 
DS 1 7 9 11 10 - - - - 1.8 
MP variant / 
AE — — « — — 3 4 9 14 " 2 7.3 
NE — — — 7 11 16 9 3 2, — ' — 4.9 
BE — 7 18 14 — — — mm — 3.2 
DS 
> 
8 8 14 2 - - - - — — 1.5 
SP variant 
AE — — — — — 29 61 37 - — 5.1 
NE — — 12 42 40 26 - - 3.7 
be — 21 71 17 - — - - - — — 2.0 
DS 24» 78 10 
' 
1.0 ; 
^Abbrevations are as follows: AE = agarose extract, NE = Noble agar extract, 
BE = Bacto agar extract, DS = dextran sulfate. 
-I b 
^ Mean plaque, diameter (mm.). 
°None observed. 
dumber of plaques . 
Table 15. Plaque diameters of the Records variants under skim milk overlays 
of varied composition 
Over-® Plaque diameter (mm.) 
lay: ôTs Ï 2 3 4 5 6 7 8 9 10 Tî 12 Mean^ 
LP variant -
SN ( 
SNCys 
SNLAH 
SA 
MP variant 
SN 
SNCys 
SNLAH 
SA 
SP variant " 
SN 30 
SNCys 2 
SNLAH 
SA 
41 
6 
11 
21 64 8 
36 
3 
14 
15 
8 
29 
2;? 
8.4 
9.6 
21 50' 6 - - - - - - - - 1.8 
6 — 17 38 1 — - ^ — — - - 3.5 
— 3 1 " 39 18 — — — — — — 5*0 
- - - - -  -  1 3  1 3  3 8  2 5  1 1 . 0  
• 
4 6  - - - - - - - - - - -  0 . 8  
77 4 - - - - - 1.1 
8- 64 6 - - - - - -- _ - 2.0 
— - 6 131 61 31 — — — . — - - 4,5 
®Abbreviations are as follows: SN = Noble agar, SNCys « Noble agar and 
cysteine, SNLAH = Noble agar and lactalbumin hydrolysate, SA = agarose; all 
modifications of the basal skim milk medium. 
^Mean plaque diameter (mm.) . 
'None observed . 
Number of plaques. 
Table 16 Changes in plaque diameter resulting from the addition of bovine 
serum to Noble agar or agarose overlays 
Plaque diameter (mm.) 
Overlay^ 0.5 1 2 3 4 5 6  ? 8 9 10 11 Mean 
LP variant -
N (-) _C 2^ 4 16 1 M 6.7 
N (S) — — — - — - 3 14 16 5 — — 7.6 
A (-) - - - - - - - 2 3 19 3 - 3.9 
A (S) -
- - - - 3 6 6 7 2 . - -• - 7.0 
MP variant 
N (-) — — — — 9 33 18 — — — — — 5.2 
N (S) — ' — 1 12 22 14 — — — - — — 4.0 
A (-) — — - — — — — — — 6 21 30 9.5 
A (S) ^  - • - - - - - 2 7 27 4 - 8.8 
SP variant 
N (-) 11 29 36 3 - — — — — — — 1.5 
N (S) 5 23 67 10 — — — - - — — - 1.8 
A (-) — 3 u  13 56 — - - - - - 4.6 
A (S) — — 3 3 7  83 — — — — — 4.7 
^•Abbreviations indicate the following; N = Noble agar (S) with, or (-) 
without serum: A = agarose (S) with, or (-) without serum. 
^Mean plaque diameter (mm.). 
°None observed. 
^Number of plaques. 
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Table 17. Neutralization of the LP Records variant by an 
antl-LP serum from chickens, and by three arbo­
virus typing sera 
Antiserum®" Plaques PPU^ Percent^ End- , 
dilution counted neutralized neutralization point 
Anti-LP serum 
1.3 8 205 99 
2.0 39 174 90 
2.7 26 187 77 3 04 
3.4 151 62 22 
Ant1-WEE serum 
1.3 1 212 100 
2.0 67 146 . ^ 78 
2.7 137 76 33 
3.4 188 25 6 
3.4 239 
2.44 
Anti-EEE serum 
1.3 197 16 8 <1.30 
2.0 287 -74 0 
2.7 294 -81 0 
3.4 280 -67 0 
-<1.30 Anti-SLE serum 
1.3 115 98 46 
2.0 275 -62 0 
2.7 280 -67 0 
3.4 280 -67 0 
Control serum 
1.3 ' 193 
2'y 208 Average count 213 0.00 
> 
^Negative Log^^ . 
^Average control count minus plaques counted. 
^Calculated according to Reed and Muench (49). 
^Negative Log^^ fifty percent endpoint. 
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Table 18. Neutralization of the MP Records variant by an 
anti-LP serum from chickens, and by three arbo­
virus typing sera 
Antiserum^ Plaques PFU^ Percent^ End-
diltuion counted neutralized neutralization point^ 
Anti-LP serum • 
1.3 
2.0 
1:1  
0 
0 
11 
39 
99 
99 88 
6o 
100 
100 
93 
55 >3.40 
Anti-WEE serum 
1.3 
2.0 
1:1  
0 
0 
11 
33 
99 
99 88 
66  
100 
100 
>3.40 
Anti-EEE serum 
1.3 
2.0 
2.7 
3.4 
18 
77  
Î I  
81 
22 
10 
15 
88 
34 
1.80 
Anti-SLE serum 
1.3 
2.0 
f.l 
0 
78 
93 
93 
99 
21 
6 
6 
100 
32 
8 
3 
1.81 
Control serum 
1.3 74 
2.0 
i l l  
117 
Average count 99 0.00 
^Negative Log^g . 
b Average control count minus plaques counted. 
^Calculated according to Reed and Muench (^9). 
^Negative Log^^ fifty percent endpoint. 
153 
Table 19. Neutralization of the SP Records variant by an 
anti-LP serum from chickens, and by three arbo­
virus typing sera 
Antiserum®" 
dilution 
Plaques 
counted 
PFU^ 
neutralized 
Percent° 
neutralization 
End- J 
point 
Anti-LP serum 
1.3 
2.0 
2.f 
3.4 
"0 
23 
44 
187 
255 
232 
211 
68 
100 
96 
81 
21 
. 3.06 
Anti-TOE serum 
1.3 
- 2.0 
n 
0 
40 
145 
251 
255 
215. 
110 
4 
100 
89 
38 
9 
• 2.54 
Anti-EEE serum 
1.3 
2.0 
2.7 
3.4 
12 
184 
289 
323 
243 . 
-34 
-68 
95 
0 
0 
0 
• 1.58 
Anti-SLE serum 
1.3 
2.0 
2.7 
3.4 
0 
198 
297 
310 
255 
97 
-42 
-55 
100 
. 38 
0 
0 
• 1.58 
Control serum 
1.3 
2.0 
2.7 
3.4 
153 
301 
280 
287 
Average count 255 . 0.00 
o ^ 
Negative Log 
Id Average control count minus plaques counted . 
°Calculated according to Reed and Muench (49). 
'^Negative Log^^ fifty percent endpoint . 
« 
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Trble 20. Neutralization-of the LP Records variant by-
guinea pig antisera (averaged data from two 
replicate trials) 
Antiserum^ 
dilution 
Plaques 
counted 
PFU^ 
neutralized 
Percent® 
neutralization 
End-
point^ 
Anti-LP serum 
1.3 
2 .0  
2.7 
• 1:1 -
0 
3 
2 
14 
29 
44 
41 
42 11 -
100 
97 
95 
71 
25 
' 3.72 
Anti-MP serum 
1.3 
2.0 
2.7 
3.4 
, 4.1 
0 J • 
38 
49 
44 
41 
28 
6 
-4 
100 
4 
0 
. 2.84 
Anti-SP serum 
1.3 
2.0 
» 
i 
41 
41 
• 39 
15 
10 
3 
97 
98 
42 .  2 .59  
Control serum 
1.3 
2 .0  
M 
It 11 
52 
Average count 44 • 0.00 
^Negative Log^^. 
^Average control count minus plaques counted. 
^Calculated according to Reed and Muench (49) . 
^Negative Log^g fifty percent endpoint. 
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Table 21. Neutralization of the MP Records variant by-
guinea pig antisera (averaged data from two 
replicate trials) 
Antiserum 
dilution 
Plaques 
counted 
PFU' Percent 
neutralized neutralization 
End-
point^ 
Anti-LP serum 
1.3 0 
2 . 0  4  
2 . 7  4  
' 3.4 14 
4.1 25 
26 
16 
5 
100 
49 
10 
3.38 
Ant1-MP serum 
1.3 
2 . 0  
2.7 
0 
2 
8 
14 
28 
30 
28 
22 
16 
2 
100 
97 
80 3.27 
Anti-SP serum 
1.3 4 
2 . 0  1 2  
2.7 22 
3.4 37 
4;1 42 
26 
18 
8 
-7 
• 1 2  
90 
30 
0 
0 
0 
1.84 
Control serum 
1 . 3  2 6  
2 . 0  2 8  
2.7 34 
3.4 30 
4.1 32 
Average count 30 0 . 0 0  
Negative Log^^. 
^Average control minus plaques counted. 
^Calculated according to Reed and Muench (49) 
^Negative Log^^ fifty percent endpoint. 
' e 
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Table 22. Neutralization of the SP Records variant by 
guinea pig antisera (averaged data from two 
replicate trials) 
Antiserum^ Plaques PFU^ Percent® End- , 
dilution counted neutralizes neutralizat ion point 
Anti-LP serum 
-
1.3 0 64 100 
2.0 3 61 98 
2.7 23 41 74 
- 3.09 
3.4 46 18 31 
4.1 49 15 11 
Anti-MP serum 
1.3 0 64 100 
2.0 15 49 86 
- 2.64 
- 2.7 28 47 
3.4 44 20 15 
4.1 67 
-3 0 
Anti-SP serum 
1.3 0 64 100 
2.0 
. 3 61 98 
2.7 19 45 84 
3.4 22 42 62 
• 3.64 
4.1 35 29 27 
Control serum 
1.3 65 
2.0 50 
count 64 2.7 75 Average • 0.00 
3.4 68 
4.1 61 
' 
^Negative Log^^. 
^Average control count minus plaques counted. 
^Calculated according to Reed and Muench (49). 
^Negative Log^g fifty percent endpoint. 
